| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR51A4 OR51A2 HCAR2 FLT3 OR9A4 OR2L3 CCR9 OR10J6P OR2L5 TMEM63B OR13H1 OR5H15 OR5H14 OR2A5 OR10T2 ABCA7 CHRNA4 CRHR1 CRHR2 CCKAR CHRNB3 CCKBR CHRND CHRNE OR1N2 HCAR3 P2RY2 ABCC8 OR5H8 OR52E8 SCN7A OR52N5 OR10K1 OR1E1 OR1E3 OR1P1 OR6K3 CCR4 TAS2R40 TAS2R31 TAS2R43 OR6C6 OR5H1 KIT OR9A2 TMEM63A | 2.59e-24 | 1353 | 115 | 46 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR51A4 OR51A2 HCAR2 OR9A4 OR2L3 CCR9 OR10J6P OR2L5 OR13H1 OR5H15 OR5H14 OR2A5 OR10T2 CRHR1 CRHR2 CCKAR CCKBR OR1N2 HCAR3 P2RY2 OR5H8 OR52E8 OR52N5 OR10K1 OR1E1 OR1E3 OR1P1 OR6K3 CCR4 TAS2R40 TAS2R31 TAS2R43 OR6C6 OR5H1 OR9A2 | 2.87e-20 | 884 | 115 | 35 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1A CACNA1B GPR89B CACNA1E TMC2 SLC39A3 SLC6A16 SLC25A14 SLC6A19 TMEM63B SLC6A15 SLC13A3 SLC13A2 ABCA7 SLC47A2 CHRNA4 CHRNB3 CHRND CHRNE CACNG2 SLC6A6 MFSD2A SIDT2 SLC10A1 CLCNKA SLC20A1 ABCC8 SLC22A3 SCN7A SLC35F6 GPR89A SLC47A1 SEC63 ATP1A4 ABCG8 SLC16A8 TMEM63A | 4.37e-18 | 1180 | 115 | 37 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | CACNA1A CACNA1B GPR89B CACNA1E TMC2 SLC39A3 SLC6A16 SLC25A14 SLC6A19 TMEM63B SLC6A15 SLC13A3 SLC13A2 ABCA7 SLC47A2 CHRNA4 CHRNB3 CHRND CHRNE CACNG2 SLC6A6 MFSD2A SIDT2 SLC10A1 CLCNKA SLC20A1 ABCC8 SLC22A3 SCN7A SLC35F6 GPR89A SLC47A1 SEC63 ATP1A4 ABCG8 SLC16A8 TMEM63A | 7.77e-17 | 1289 | 115 | 37 | GO:0005215 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR51A4 OR51A2 OR9A4 OR2L3 OR10J6P OR2L5 OR13H1 OR5H15 OR5H14 OR2A5 OR10T2 OR1N2 OR5H8 OR52E8 OR52N5 OR10K1 OR1E1 OR1E3 OR1P1 OR6K3 OR6C6 OR5H1 OR9A2 | 3.97e-16 | 431 | 115 | 23 | GO:0004984 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1A CACNA1B GPR89B CACNA1E TMC2 SLC39A3 SLC25A14 TMEM63B SLC6A15 SLC13A3 SLC13A2 SLC47A2 CHRNA4 CHRNB3 CHRND CHRNE CACNG2 SLC6A6 MFSD2A SLC10A1 CLCNKA SLC20A1 ABCC8 SLC22A3 SCN7A GPR89A SLC47A1 ATP1A4 TMEM63A | 7.56e-16 | 793 | 115 | 29 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1A CACNA1B CACNA1E TMC2 SLC39A3 SLC25A14 TMEM63B SLC6A15 SLC13A3 SLC13A2 SLC47A2 CHRNA4 CHRNB3 CHRND CHRNE CACNG2 SLC6A6 MFSD2A SLC10A1 SLC20A1 ABCC8 SLC22A3 SCN7A SLC47A1 ATP1A4 TMEM63A | 6.20e-15 | 664 | 115 | 26 | GO:0008324 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1A CACNA1B CACNA1E TMC2 SLC39A3 SLC25A14 TMEM63B SLC6A15 SLC13A3 SLC13A2 SLC47A2 CACNG2 SLC6A6 MFSD2A SLC10A1 SLC20A1 ABCC8 SLC22A3 SCN7A SLC47A1 ATP1A4 TMEM63A | 8.70e-12 | 627 | 115 | 22 | GO:0022890 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1A CACNA1B CACNA1E TMC2 SLC39A3 SLC25A14 TMEM63B SLC6A15 SLC13A3 SLC13A2 SLC47A2 CACNG2 SLC6A6 MFSD2A SLC10A1 CLCNKA SLC20A1 ABCC8 SLC22A3 SCN7A SLC47A1 ATP1A4 TMEM63A | 5.10e-11 | 758 | 115 | 23 | GO:0015318 |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1A CACNA1B GPR89B CACNA1E TMC2 TMEM63B CHRNA4 CHRNB3 CHRND CHRNE CACNG2 CLCNKA ABCC8 SCN7A GPR89A TMEM63A | 8.80e-11 | 334 | 115 | 16 | GO:0022836 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC6A16 SLC25A14 SLC6A19 SLC6A15 SLC13A3 SLC13A2 ABCA7 SLC47A2 SLC6A6 MFSD2A SLC10A1 SLC20A1 ABCC8 SLC22A3 SLC47A1 ATP1A4 ABCG8 SLC16A8 | 2.62e-10 | 477 | 115 | 18 | GO:0022804 |
| GeneOntologyMolecularFunction | symporter activity | SLC6A16 SLC6A19 SLC6A15 SLC13A3 SLC13A2 SLC6A6 MFSD2A SLC10A1 SLC20A1 SLC22A3 SLC16A8 | 1.08e-09 | 150 | 115 | 11 | GO:0015293 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1A CACNA1B CACNA1E TMC2 SLC39A3 SLC6A15 SLC13A3 SLC13A2 CACNG2 SLC6A6 MFSD2A SLC10A1 SLC20A1 ABCC8 SLC22A3 SCN7A ATP1A4 | 1.40e-09 | 465 | 115 | 17 | GO:0046873 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC6A16 SLC25A14 SLC6A19 SLC6A15 SLC13A3 SLC13A2 SLC47A2 SLC6A6 MFSD2A SLC10A1 SLC20A1 SLC22A3 SLC47A1 SLC16A8 | 1.70e-09 | 296 | 115 | 14 | GO:0015291 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1A CACNA1B GPR89B CACNA1E TMC2 TMEM63B CHRNA4 CHRNB3 CHRND CHRNE CACNG2 CLCNKA ABCC8 SCN7A GPR89A TMEM63A | 8.72e-09 | 459 | 115 | 16 | GO:0005216 |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | SLC6A15 SLC13A3 SLC13A2 SLC6A6 MFSD2A SLC10A1 SLC20A1 SLC22A3 | 2.15e-08 | 81 | 115 | 8 | GO:0015370 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SLC6A15 SLC13A3 SLC13A2 SLC6A6 MFSD2A SLC10A1 SLC20A1 SLC22A3 SCN7A ATP1A4 | 5.60e-08 | 171 | 115 | 10 | GO:0015081 |
| GeneOntologyMolecularFunction | channel activity | CACNA1A CACNA1B GPR89B CACNA1E TMC2 TMEM63B CHRNA4 CHRNB3 CHRND CHRNE CACNG2 CLCNKA ABCC8 SCN7A GPR89A TMEM63A | 5.66e-08 | 525 | 115 | 16 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1A CACNA1B GPR89B CACNA1E TMC2 TMEM63B CHRNA4 CHRNB3 CHRND CHRNE CACNG2 CLCNKA ABCC8 SCN7A GPR89A TMEM63A | 5.81e-08 | 526 | 115 | 16 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1A CACNA1B CACNA1E TMC2 TMEM63B CHRNA4 CHRNB3 CHRND CHRNE CACNG2 ABCC8 SCN7A TMEM63A | 9.14e-08 | 343 | 115 | 13 | GO:0005261 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC6A15 SLC13A3 SLC13A2 SLC47A2 SLC6A6 MFSD2A SLC10A1 SLC20A1 ABCC8 SLC22A3 SLC47A1 ATP1A4 | 1.71e-07 | 301 | 115 | 12 | GO:0022853 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | SLC6A15 SLC13A3 SLC13A2 SLC6A6 MFSD2A SLC10A1 SLC20A1 SLC22A3 | 4.36e-07 | 119 | 115 | 8 | GO:0015294 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | CACNA1A CACNA1B GPR89B CACNA1E TMC2 CACNG2 CLCNKA ABCC8 GPR89A | 1.09e-06 | 182 | 115 | 9 | GO:0005244 |
| GeneOntologyMolecularFunction | voltage-gated channel activity | CACNA1A CACNA1B GPR89B CACNA1E TMC2 CACNG2 CLCNKA ABCC8 GPR89A | 1.20e-06 | 184 | 115 | 9 | GO:0022832 |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 1.64e-06 | 35 | 115 | 5 | GO:0005343 | |
| GeneOntologyMolecularFunction | osmolarity-sensing monoatomic cation channel activity | 1.85e-06 | 5 | 115 | 3 | GO:1990760 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 2.34e-06 | 17 | 115 | 4 | GO:0022848 | |
| GeneOntologyMolecularFunction | osmosensor activity | 3.68e-06 | 6 | 115 | 3 | GO:0005034 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 6.59e-06 | 46 | 115 | 5 | GO:0005245 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 8.49e-06 | 23 | 115 | 4 | GO:0015464 | |
| GeneOntologyMolecularFunction | odorant binding | 8.84e-06 | 127 | 115 | 7 | GO:0005549 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 1.52e-05 | 9 | 115 | 3 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 1.52e-05 | 9 | 115 | 3 | GO:0099626 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.67e-05 | 140 | 115 | 7 | GO:0099094 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC6A15 SLC13A3 SLC13A2 SLC6A6 MFSD2A SLC10A1 SLC47A1 SLC16A8 | 2.67e-05 | 207 | 115 | 8 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC6A15 SLC13A3 SLC13A2 SLC6A6 MFSD2A SLC10A1 SLC47A1 SLC16A8 | 2.76e-05 | 208 | 115 | 8 | GO:0005342 |
| GeneOntologyMolecularFunction | polyspecific organic cation:proton antiporter activity | 3.29e-05 | 2 | 115 | 2 | GO:0140968 | |
| GeneOntologyMolecularFunction | cholecystokinin receptor activity | 3.29e-05 | 2 | 115 | 2 | GO:0004951 | |
| GeneOntologyMolecularFunction | nicotinic acid receptor activity | 3.29e-05 | 2 | 115 | 2 | GO:0070553 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC6A15 SLC13A3 SLC13A2 SLC6A6 MFSD2A SLC10A1 SLC22A3 SLC47A1 SLC16A8 | 5.04e-05 | 293 | 115 | 9 | GO:0008514 |
| GeneOntologyMolecularFunction | acetylcholine binding | 5.10e-05 | 13 | 115 | 3 | GO:0042166 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 6.47e-05 | 14 | 115 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | sodium:dicarboxylate symporter activity | 9.83e-05 | 3 | 115 | 2 | GO:0017153 | |
| GeneOntologyMolecularFunction | corticotropin-releasing hormone receptor activity | 9.83e-05 | 3 | 115 | 2 | GO:0043404 | |
| GeneOntologyMolecularFunction | corticotrophin-releasing factor receptor activity | 9.83e-05 | 3 | 115 | 2 | GO:0015056 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 1.08e-04 | 43 | 115 | 4 | GO:0005231 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 1.19e-04 | 17 | 115 | 3 | GO:0008308 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.28e-04 | 193 | 115 | 7 | GO:0015276 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 1.43e-04 | 18 | 115 | 3 | GO:0008381 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.46e-04 | 197 | 115 | 7 | GO:0022834 | |
| GeneOntologyMolecularFunction | neurotransmitter transmembrane transporter activity | 2.29e-04 | 21 | 115 | 3 | GO:0005326 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 2.42e-04 | 151 | 115 | 6 | GO:0008509 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 2.51e-04 | 152 | 115 | 6 | GO:0022843 | |
| GeneOntologyMolecularFunction | nucleotide receptor activity | 2.65e-04 | 22 | 115 | 3 | GO:0016502 | |
| GeneOntologyMolecularFunction | purinergic nucleotide receptor activity | 2.65e-04 | 22 | 115 | 3 | GO:0001614 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 2.84e-04 | 55 | 115 | 4 | GO:0017046 | |
| GeneOntologyMolecularFunction | hormone binding | 3.24e-04 | 103 | 115 | 5 | GO:0042562 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 3.26e-04 | 57 | 115 | 4 | GO:1904315 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 3.55e-04 | 105 | 115 | 5 | GO:0015171 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 3.97e-04 | 60 | 115 | 4 | GO:0099529 | |
| GeneOntologyMolecularFunction | succinate transmembrane transporter activity | 4.86e-04 | 6 | 115 | 2 | GO:0015141 | |
| GeneOntologyMolecularFunction | alpha-ketoglutarate transmembrane transporter activity | 4.86e-04 | 6 | 115 | 2 | GO:0015139 | |
| GeneOntologyMolecularFunction | bitter taste receptor activity | 4.92e-04 | 27 | 115 | 3 | GO:0033038 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 5.39e-04 | 65 | 115 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 5.39e-04 | 65 | 115 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | taste receptor activity | 8.95e-04 | 33 | 115 | 3 | GO:0008527 | |
| GeneOntologyMolecularFunction | aspartic endopeptidase activity, intramembrane cleaving | 9.00e-04 | 8 | 115 | 2 | GO:0042500 | |
| GeneOntologyMolecularFunction | calcium channel activity | 9.06e-04 | 129 | 115 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 9.26e-04 | 75 | 115 | 4 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.02e-03 | 77 | 115 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 1.35e-03 | 83 | 115 | 4 | GO:0015101 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 1.69e-03 | 41 | 115 | 3 | GO:0015175 | |
| GeneOntologyMolecularFunction | amide binding | 1.74e-03 | 299 | 115 | 7 | GO:0033218 | |
| GeneOntologyMolecularFunction | polyamine transmembrane transporter activity | 1.75e-03 | 11 | 115 | 2 | GO:0015203 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.82e-03 | 151 | 115 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.82e-03 | 90 | 115 | 4 | GO:0008028 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 2.68e-03 | 100 | 115 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 2.83e-03 | 49 | 115 | 3 | GO:0140359 | |
| GeneOntologyMolecularFunction | molecular sensor activity | 3.00e-03 | 50 | 115 | 3 | GO:0140299 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 3.12e-03 | 171 | 115 | 5 | GO:0015103 | |
| GeneOntologyMolecularFunction | C4-dicarboxylate transmembrane transporter activity | 3.29e-03 | 15 | 115 | 2 | GO:0015556 | |
| GeneOntologyMolecularFunction | monocarboxylate:sodium symporter activity | 3.29e-03 | 15 | 115 | 2 | GO:0140161 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 3.65e-03 | 109 | 115 | 4 | GO:0042626 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 4.23e-03 | 17 | 115 | 2 | GO:0015378 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 5.25e-03 | 61 | 115 | 3 | GO:1901682 | |
| GeneOntologyMolecularFunction | secondary active monocarboxylate transmembrane transporter activity | 5.27e-03 | 19 | 115 | 2 | GO:0015355 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 5.27e-03 | 19 | 115 | 2 | GO:0015373 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 5.93e-03 | 125 | 115 | 4 | GO:0015108 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 7.36e-03 | 133 | 115 | 4 | GO:0008528 | |
| GeneOntologyMolecularFunction | C-C chemokine receptor activity | 7.69e-03 | 23 | 115 | 2 | GO:0016493 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR51A4 OR51A2 OR9A4 TMC2 OR2L3 OR10J6P OR2L5 OR13H1 OR5H15 OR5H14 OR2A5 OR10T2 OR1N2 OR5H8 OR52E8 OR52N5 OR10K1 OR1E1 OR1E3 OR1P1 OR6K3 TAS2R40 TAS2R31 TAS2R43 OR6C6 OR5H1 KIT OR9A2 | 2.09e-18 | 582 | 118 | 28 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR51A4 OR51A2 OR9A4 OR2L3 OR10J6P OR2L5 OR13H1 OR5H15 OR5H14 OR2A5 OR10T2 OR1N2 OR5H8 OR52E8 OR52N5 OR10K1 OR1E1 OR1E3 OR1P1 OR6K3 TAS2R40 TAS2R31 TAS2R43 OR6C6 OR5H1 OR9A2 | 2.94e-18 | 485 | 118 | 26 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR51A4 OR51A2 OR9A4 OR2L3 OR10J6P OR2L5 OR13H1 OR5H15 OR5H14 OR2A5 OR10T2 OR1N2 OR5H8 OR52E8 OR52N5 OR10K1 OR1E1 OR1E3 OR1P1 OR6K3 TAS2R40 TAS2R31 TAS2R43 OR6C6 OR5H1 OR9A2 | 1.95e-17 | 524 | 118 | 26 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR51A4 OR51A2 OR9A4 OR2L3 OR10J6P OR2L5 OR13H1 OR5H15 OR5H14 OR2A5 OR10T2 OR1N2 OR5H8 OR52E8 OR52N5 OR10K1 OR1E1 OR1E3 OR1P1 OR6K3 TAS2R40 TAS2R31 TAS2R43 OR6C6 OR5H1 OR9A2 | 5.52e-17 | 547 | 118 | 26 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR51A4 OR51A2 OR9A4 OR2L3 OR10J6P OR2L5 OR13H1 OR5H15 OR5H14 OR2A5 OR10T2 OR1N2 OR5H8 OR52E8 OR52N5 OR10K1 OR1E1 OR1E3 OR1P1 OR6K3 OR6C6 OR5H1 OR9A2 | 3.82e-16 | 432 | 118 | 23 | GO:0050911 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR51A4 OR51A2 OR9A4 TMC2 OR2L3 OR10J6P OR2L5 OR13H1 OR5H15 OR5H14 OR2A5 OR10T2 OR1N2 OR5H8 OR52E8 OR52N5 OR10K1 OR1E1 OR1E3 OR1P1 OR6K3 TAS2R40 TAS2R31 TAS2R43 OR6C6 OR5H1 KIT OR9A2 | 5.43e-16 | 722 | 118 | 28 | GO:0051606 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1A CACNA1B GPR89B CACNA1E TMC2 SLC39A3 SLC6A16 SLC25A14 SLC6A19 TMEM63B SLC6A15 SLC13A3 CLDN15 SLC13A2 SLC47A2 CHRNA4 CRHR1 CRHR2 CCKAR CHRNB3 CHRND CHRNE CACNG2 SLC6A6 SLC10A1 CD19 CLCNKA MAGED2 SLC20A1 ABCC8 SLC22A3 SCN7A GPR89A SLC47A1 TRIM13 ATP1A4 TMEM63A | 5.56e-16 | 1374 | 118 | 37 | GO:0006811 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR51A4 OR51A2 OR9A4 OR2L3 OR10J6P OR2L5 OR13H1 OR5H15 OR5H14 OR2A5 OR10T2 OR1N2 OR5H8 OR52E8 OR52N5 OR10K1 OR1E1 OR1E3 OR1P1 OR6K3 OR6C6 OR5H1 OR9A2 | 1.87e-15 | 465 | 118 | 23 | GO:0007608 |
| GeneOntologyBiologicalProcess | sensory perception | OR51A4 OR51A2 CACNA1E OR9A4 TMC2 OR2L3 OR10J6P OR2L5 TMEM63B OR13H1 OR5H15 OR5H14 OTOR OR2A5 OR10T2 CHRNA4 OR1N2 OR5H8 OR52E8 OR52N5 OR10K1 OR1E1 OR1E3 OR1P1 OR6K3 TAS2R40 TAS2R31 TAS2R43 OR6C6 OR5H1 KIT OR9A2 | 5.06e-15 | 1072 | 118 | 32 | GO:0007600 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR51A4 OR51A2 HCAR2 OR9A4 OR2L3 CCR9 OR10J6P OR2L5 OR13H1 OR5H15 OR5H14 OR2A5 APELA OR10T2 CRHR1 CRHR2 CCKAR CCKBR OR1N2 HCAR3 P2RY2 OR5H8 OR52E8 OR52N5 OR10K1 OR1E1 OR1E3 OR1P1 OR6K3 CCR4 TAS2R40 TAS2R31 TAS2R43 OR6C6 OR5H1 OR9A2 | 5.77e-15 | 1395 | 118 | 36 | GO:0007186 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1A CACNA1B GPR89B CACNA1E TMC2 SLC39A3 SLC6A16 SLC25A14 SLC6A19 TMEM63B SLC6A15 SLC13A3 SLC13A2 SLC47A2 CHRNA4 CRHR1 CHRNB3 CHRND CHRNE CACNG2 SLC6A6 CD19 CLCNKA SLC20A1 ABCC8 SCN7A GPR89A SLC47A1 TRIM13 ATP1A4 TMEM63A | 1.00e-13 | 1115 | 118 | 31 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1A CACNA1B CACNA1E TMC2 SLC39A3 SLC6A16 SLC25A14 SLC6A19 TMEM63B SLC6A15 SLC13A3 SLC13A2 SLC47A2 CHRNA4 CRHR1 CRHR2 CCKAR CHRND CHRNE CACNG2 SLC6A6 SLC10A1 CD19 MAGED2 SLC20A1 ABCC8 SCN7A SLC47A1 TRIM13 ATP1A4 TMEM63A | 2.67e-13 | 1157 | 118 | 31 | GO:0006812 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1A CACNA1B CACNA1E TMC2 SLC39A3 SLC6A16 SLC25A14 SLC6A19 TMEM63B SLC6A15 SLC13A3 SLC13A2 SLC47A2 CRHR1 CHRNE CACNG2 SLC6A6 CD19 SLC20A1 ABCC8 SCN7A SLC47A1 TRIM13 ATP1A4 TMEM63A | 1.02e-10 | 942 | 118 | 25 | GO:0098655 |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1A CACNA1B CACNA1E TMC2 SLC39A3 SLC6A16 SLC6A19 SLC6A15 SLC13A3 SLC13A2 CHRNA4 CRHR1 CRHR2 CCKAR CACNG2 SLC6A6 SLC10A1 CD19 MAGED2 SLC20A1 ABCC8 SCN7A TRIM13 ATP1A4 | 1.92e-09 | 1000 | 118 | 24 | GO:0030001 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1A CACNA1B CACNA1E TMC2 SLC39A3 SLC6A16 SLC25A14 SLC6A19 SLC6A15 SLC13A3 SLC13A2 SLC47A2 CRHR1 CACNG2 SLC6A6 CD19 SLC20A1 ABCC8 SCN7A SLC47A1 TRIM13 ATP1A4 | 1.12e-08 | 922 | 118 | 22 | GO:0098662 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1A CACNA1B CACNA1E TMC2 SLC39A3 SLC6A16 SLC25A14 SLC6A19 SLC6A15 SLC13A3 SLC13A2 SLC47A2 CRHR1 CACNG2 SLC6A6 CD19 CLCNKA SLC20A1 ABCC8 SCN7A SLC47A1 TRIM13 ATP1A4 | 1.35e-08 | 1017 | 118 | 23 | GO:0098660 |
| GeneOntologyBiologicalProcess | organic cation transport | CACNA1A SLC6A15 SLC47A2 CRHR1 CRHR2 SLC6A6 SLC22A3 SLC47A1 LY6E | 1.52e-07 | 145 | 118 | 9 | GO:0015695 |
| GeneOntologyBiologicalProcess | sodium ion transport | SLC6A16 SLC6A19 SLC6A15 SLC13A3 SLC13A2 SLC6A6 SLC10A1 MAGED2 SLC20A1 SCN7A ATP1A4 | 5.26e-07 | 275 | 118 | 11 | GO:0006814 |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | APOC2 ABCA7 CHRNA4 CRHR1 CRHR2 SLC10A1 SLC22A3 TMEM97 LY6E ABCG8 SOAT2 SLC16A8 | 1.02e-06 | 358 | 118 | 12 | GO:0015850 |
| GeneOntologyBiologicalProcess | epinephrine transport | 2.29e-06 | 17 | 118 | 4 | GO:0048241 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | SLC6A16 SLC6A19 SLC6A15 SLC13A3 SLC13A2 SLC6A6 SLC20A1 SCN7A ATP1A4 | 3.14e-06 | 208 | 118 | 9 | GO:0035725 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | CACNA1A SLC6A15 SLC13A3 SLC13A2 SLC6A6 MFSD2A SLC10A1 P2RY2 ABCC8 SLC22A3 SLC47A1 SLC16A8 | 4.15e-06 | 410 | 118 | 12 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | CACNA1A SLC6A15 SLC13A3 SLC13A2 SLC6A6 MFSD2A SLC10A1 P2RY2 ABCC8 SLC22A3 SLC47A1 SLC16A8 | 4.36e-06 | 412 | 118 | 12 | GO:0015849 |
| GeneOntologyBiologicalProcess | synaptic transmission, cholinergic | 5.11e-06 | 44 | 118 | 5 | GO:0007271 | |
| GeneOntologyBiologicalProcess | regulation of somatostatin secretion | 6.28e-06 | 7 | 118 | 3 | GO:0090273 | |
| GeneOntologyBiologicalProcess | export from cell | CACNA1A CACNA1B CACNA1E HCAR2 CD177 SLC47A2 CHRNA4 CRHR1 CRHR2 CCKAR CCKBR HCAR3 SIDT2 P2RY2 ABCC8 SLC47A1 LY6E ATP1A4 KIT TANGO6 | 8.18e-06 | 1153 | 118 | 20 | GO:0140352 |
| GeneOntologyBiologicalProcess | acetylcholine receptor signaling pathway | 1.07e-05 | 51 | 118 | 5 | GO:0095500 | |
| GeneOntologyBiologicalProcess | cellular response to acetylcholine | 1.30e-05 | 53 | 118 | 5 | GO:1905145 | |
| GeneOntologyBiologicalProcess | somatostatin secretion | 1.50e-05 | 9 | 118 | 3 | GO:0070253 | |
| GeneOntologyBiologicalProcess | amino acid transport | CACNA1A SLC6A16 SLC6A19 SLC6A15 SLC13A3 SLC6A6 ABCC8 SLC47A1 | 1.66e-05 | 195 | 118 | 8 | GO:0006865 |
| GeneOntologyBiologicalProcess | response to acetylcholine | 1.70e-05 | 56 | 118 | 5 | GO:1905144 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | CACNA1A CACNA1B CACNA1E SLC6A16 SLC6A15 SLC6A6 P2RY2 ABCC8 SLC22A3 | 1.84e-05 | 259 | 118 | 9 | GO:0006836 |
| GeneOntologyBiologicalProcess | secretion | CACNA1A CACNA1B CACNA1E HCAR2 CD177 TMEM63B CHRNA4 CRHR1 CRHR2 CCKAR CCKBR HCAR3 SIDT2 SLC10A1 P2RY2 ABCC8 LY6E KIT TANGO6 TMEM63A | 1.89e-05 | 1221 | 118 | 20 | GO:0046903 |
| GeneOntologyBiologicalProcess | chemical homeostasis | CACNA1A GPR89B LETM2 CACNA1E TMEM63B APOC2 CRHR2 CCKBR SIDT2 ADIPOR1 CD19 P2RY2 ABCC8 SCN7A GPR89A TMEM97 ATP1A4 ABCG8 SOAT2 TMEM63A | 2.61e-05 | 1249 | 118 | 20 | GO:0048878 |
| GeneOntologyBiologicalProcess | surfactant secretion | 3.25e-05 | 2 | 118 | 2 | GO:0160069 | |
| GeneOntologyBiologicalProcess | organic anion transport | CACNA1A SLC6A15 SLC13A3 SLC13A2 SLC6A6 MFSD2A SLC10A1 P2RY2 ABCC8 SLC22A3 SLC47A1 SLC16A8 | 4.00e-05 | 515 | 118 | 12 | GO:0015711 |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 4.48e-05 | 224 | 118 | 8 | GO:0007204 | |
| GeneOntologyBiologicalProcess | postsynaptic signal transduction | 4.72e-05 | 69 | 118 | 5 | GO:0098926 | |
| GeneOntologyBiologicalProcess | epinephrine secretion | 5.01e-05 | 13 | 118 | 3 | GO:0048242 | |
| GeneOntologyBiologicalProcess | regulation of secretion | CACNA1A CACNA1B CACNA1E HCAR2 CD177 CHRNA4 CRHR1 CRHR2 CCKAR CCKBR HCAR3 SIDT2 SLC10A1 P2RY2 ABCC8 | 5.29e-05 | 801 | 118 | 15 | GO:0051046 |
| GeneOntologyBiologicalProcess | membrane depolarization | 6.94e-05 | 121 | 118 | 6 | GO:0051899 | |
| GeneOntologyBiologicalProcess | visual learning | 8.51e-05 | 78 | 118 | 5 | GO:0008542 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | CACNA1A CACNA1B CACNA1E HCAR2 CD177 CHRNA4 CRHR1 CRHR2 CCKAR CCKBR HCAR3 SIDT2 P2RY2 ABCC8 | 8.58e-05 | 740 | 118 | 14 | GO:1903530 |
| GeneOntologyBiologicalProcess | signal release | CACNA1A CACNA1B CACNA1E HCAR2 CHRNA4 CRHR1 CRHR2 CCKAR CCKBR HCAR3 SIDT2 P2RY2 ABCC8 | 9.40e-05 | 653 | 118 | 13 | GO:0023061 |
| GeneOntologyBiologicalProcess | cholecystokinin signaling pathway | 9.70e-05 | 3 | 118 | 2 | GO:0038188 | |
| GeneOntologyBiologicalProcess | positive regulation of secretion by cell | CACNA1B HCAR2 CD177 CRHR1 CRHR2 CCKAR CCKBR HCAR3 P2RY2 ABCC8 | 1.11e-04 | 404 | 118 | 10 | GO:1903532 |
| GeneOntologyBiologicalProcess | secretion by cell | CACNA1A CACNA1B CACNA1E HCAR2 CD177 CHRNA4 CRHR1 CRHR2 CCKAR CCKBR HCAR3 SIDT2 P2RY2 ABCC8 LY6E KIT TANGO6 | 1.16e-04 | 1064 | 118 | 17 | GO:0032940 |
| GeneOntologyBiologicalProcess | visual behavior | 1.35e-04 | 86 | 118 | 5 | GO:0007632 | |
| GeneOntologyBiologicalProcess | synaptic signaling | CACNA1A CACNA1B CACNA1E CHRNA4 CRHR1 CRHR2 CHRNB3 CCKBR CHRND CHRNE CACNG2 SLC6A6 P2RY2 ABCC8 LY6E KIT | 1.40e-04 | 976 | 118 | 16 | GO:0099536 |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 1.43e-04 | 87 | 118 | 5 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 1.51e-04 | 88 | 118 | 5 | GO:0010232 | |
| GeneOntologyBiologicalProcess | positive regulation of adiponectin secretion | 1.93e-04 | 4 | 118 | 2 | GO:0070165 | |
| GeneOntologyBiologicalProcess | positive regulation of somatostatin secretion | 1.93e-04 | 4 | 118 | 2 | GO:0090274 | |
| GeneOntologyBiologicalProcess | positive regulation of secretion | CACNA1B HCAR2 CD177 CRHR1 CRHR2 CCKAR CCKBR HCAR3 P2RY2 ABCC8 | 2.01e-04 | 435 | 118 | 10 | GO:0051047 |
| GeneOntologyBiologicalProcess | regulation of hormone secretion | 2.06e-04 | 355 | 118 | 9 | GO:0046883 | |
| GeneOntologyBiologicalProcess | response to pain | 2.07e-04 | 51 | 118 | 4 | GO:0048265 | |
| GeneOntologyBiologicalProcess | catecholamine transport | 2.27e-04 | 96 | 118 | 5 | GO:0051937 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | CACNA1A CACNA1B CACNA1E CHRNA4 CRHR1 CRHR2 CHRNB3 CCKBR CHRND CHRNE CACNG2 SLC6A6 P2RY2 ABCC8 KIT | 2.76e-04 | 931 | 118 | 15 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | CACNA1A CACNA1B CACNA1E CHRNA4 CRHR1 CRHR2 CHRNB3 CCKBR CHRND CHRNE CACNG2 SLC6A6 P2RY2 ABCC8 KIT | 2.76e-04 | 931 | 118 | 15 | GO:0007268 |
| GeneOntologyBiologicalProcess | plasma lipoprotein particle organization | 2.77e-04 | 55 | 118 | 4 | GO:0071827 | |
| GeneOntologyBiologicalProcess | circulatory system process | CACNA1B CACNA1E DSG2 SLC13A3 APELA CRHR2 SLC6A6 MFSD2A P2RY2 ABCC8 SLC22A3 SCN7A ATP1A4 | 2.92e-04 | 733 | 118 | 13 | GO:0003013 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | CACNA1A CACNA1B CACNA1E CHRNA4 CRHR1 CRHR2 CHRNB3 CCKBR CHRND CHRNE CACNG2 SLC6A6 P2RY2 ABCC8 KIT | 3.03e-04 | 939 | 118 | 15 | GO:0099537 |
| GeneOntologyBiologicalProcess | regulation of plasma lipoprotein particle levels | 3.15e-04 | 103 | 118 | 5 | GO:0097006 | |
| GeneOntologyBiologicalProcess | acid secretion | 3.18e-04 | 57 | 118 | 4 | GO:0046717 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 3.62e-04 | 230 | 118 | 7 | GO:0098739 | |
| GeneOntologyBiologicalProcess | protein-lipid complex organization | 3.63e-04 | 59 | 118 | 4 | GO:0071825 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 4.02e-04 | 167 | 118 | 6 | GO:1903825 | |
| GeneOntologyBiologicalProcess | lipid localization | SMIM22 SLC13A3 APOC2 ABCA7 CRHR1 MFSD2A SLC10A1 P2RY2 TMEM97 ABCG8 SOAT2 | 4.02e-04 | 565 | 118 | 11 | GO:0010876 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | CACNA1A CACNA1B CACNA1E CHRNA4 CRHR1 CRHR2 CHRNB3 CCKBR CACNG2 SLC6A6 P2RY2 KIT | 4.21e-04 | 663 | 118 | 12 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | CACNA1A CACNA1B CACNA1E CHRNA4 CRHR1 CRHR2 CHRNB3 CCKBR CACNG2 SLC6A6 P2RY2 KIT | 4.26e-04 | 664 | 118 | 12 | GO:0099177 |
| GeneOntologyBiologicalProcess | cellular response to corticotropin-releasing hormone stimulus | 4.80e-04 | 6 | 118 | 2 | GO:0071376 | |
| GeneOntologyBiologicalProcess | succinate transmembrane transport | 4.80e-04 | 6 | 118 | 2 | GO:0071422 | |
| GeneOntologyBiologicalProcess | succinate transport | 4.80e-04 | 6 | 118 | 2 | GO:0015744 | |
| GeneOntologyBiologicalProcess | response to corticotropin-releasing hormone | 4.80e-04 | 6 | 118 | 2 | GO:0043435 | |
| GeneOntologyBiologicalProcess | monoamine transport | 5.44e-04 | 116 | 118 | 5 | GO:0015844 | |
| GeneOntologyBiologicalProcess | plasma lipoprotein particle assembly | 5.98e-04 | 29 | 118 | 3 | GO:0034377 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 6.35e-04 | 120 | 118 | 5 | GO:0003333 | |
| GeneOntologyBiologicalProcess | lipid transport | SLC13A3 APOC2 ABCA7 CRHR1 MFSD2A SLC10A1 P2RY2 TMEM97 ABCG8 SOAT2 | 6.61e-04 | 506 | 118 | 10 | GO:0006869 |
| GeneOntologyBiologicalProcess | alpha-ketoglutarate transport | 6.69e-04 | 7 | 118 | 2 | GO:0015742 | |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNA1A CACNA1B CACNA1E TMC2 CHRNA4 CRHR1 CRHR2 CCKAR CACNG2 CD19 | 6.92e-04 | 509 | 118 | 10 | GO:0006816 |
| GeneOntologyBiologicalProcess | hormone secretion | 6.99e-04 | 420 | 118 | 9 | GO:0046879 | |
| GeneOntologyBiologicalProcess | reflex | 7.30e-04 | 31 | 118 | 3 | GO:0060004 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 7.92e-04 | 126 | 118 | 5 | GO:0033555 | |
| GeneOntologyBiologicalProcess | digestive system process | 7.92e-04 | 126 | 118 | 5 | GO:0022600 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 8.02e-04 | 32 | 118 | 3 | GO:0048266 | |
| GeneOntologyBiologicalProcess | hormone transport | 8.53e-04 | 432 | 118 | 9 | GO:0009914 | |
| GeneOntologyBiologicalProcess | protein-lipid complex assembly | 8.79e-04 | 33 | 118 | 3 | GO:0065005 | |
| GeneOntologyBiologicalProcess | adiponectin secretion | 8.88e-04 | 8 | 118 | 2 | GO:0070162 | |
| GeneOntologyBiologicalProcess | regulation of adiponectin secretion | 8.88e-04 | 8 | 118 | 2 | GO:0070163 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | CACNA1A CACNA1B FLT3 MARCHF6 RAET1E HM13 CHRNA4 CRHR1 CRHR2 CHRNB3 CHRND CHRNE ADIPOR1 P2RY2 ABCC8 LY6E TRIM13 | 9.12e-04 | 1272 | 118 | 17 | GO:1901698 |
| GeneOntologyBiologicalProcess | associative learning | 9.12e-04 | 130 | 118 | 5 | GO:0008306 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid catabolic process | 9.60e-04 | 34 | 118 | 3 | GO:0050995 | |
| GeneOntologyBiologicalProcess | cholesterol efflux | 9.98e-04 | 77 | 118 | 4 | GO:0033344 | |
| GeneOntologyBiologicalProcess | endocrine hormone secretion | 9.98e-04 | 77 | 118 | 4 | GO:0060986 | |
| GeneOntologyBiologicalProcess | cholesterol transport | 1.04e-03 | 134 | 118 | 5 | GO:0030301 | |
| GeneOntologyBiologicalProcess | regulation of lipid catabolic process | 1.05e-03 | 78 | 118 | 4 | GO:0050994 | |
| GeneOntologyBiologicalProcess | catecholamine secretion | 1.10e-03 | 79 | 118 | 4 | GO:0050432 | |
| GeneOntologyBiologicalProcess | import into cell | CACNA1A CACNA1B CACNA1E TIMD4 CD177 IFITM1 APOC2 APELA ABCA7 CACNG2 SLC6A6 ABCC8 SLC22A3 SLC47A1 ATP1A4 | 1.21e-03 | 1074 | 118 | 15 | GO:0098657 |
| GeneOntologyBiologicalProcess | sterol transport | 1.23e-03 | 139 | 118 | 5 | GO:0015918 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 1.35e-03 | 142 | 118 | 5 | GO:0099587 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1A CACNA1B GPR89B CACNA1E CHRNA4 CHRNB3 CHRND CHRNE CACNG2 CLCNKA ABCC8 SCN7A GPR89A | 2.49e-07 | 378 | 119 | 13 | GO:0034702 |
| GeneOntologyCellularComponent | apical part of cell | SLC39A3 DSG2 TMEM114 SLC6A19 IFITM1 SLC13A2 ABCA7 SLC47A2 CRHR1 SLC6A6 CLCNKA P2RY2 SLC22A3 SLC47A1 ABCG8 SLC16A8 | 2.54e-07 | 592 | 119 | 16 | GO:0045177 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1A CACNA1B GPR89B CACNA1E CHRNA4 CHRNB3 CHRND CHRNE CACNG2 CLCNKA ABCC8 SCN7A GPR89A ATP1A4 ABCG8 | 2.93e-07 | 523 | 119 | 15 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | CACNA1A CACNA1B GPR89B CACNA1E CHRNA4 CHRNB3 CHRND CHRNE CACNG2 CLCNKA ABCC8 SCN7A GPR89A ATP1A4 ABCG8 | 5.54e-07 | 550 | 119 | 15 | GO:1990351 |
| GeneOntologyCellularComponent | apical plasma membrane | SLC39A3 DSG2 TMEM114 SLC6A19 SLC13A2 ABCA7 SLC47A2 SLC6A6 CLCNKA P2RY2 SLC22A3 SLC47A1 ABCG8 SLC16A8 | 7.30e-07 | 487 | 119 | 14 | GO:0016324 |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 2.87e-06 | 18 | 119 | 4 | GO:0005892 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | SLC13A3 SLC6A6 SLC10A1 CLCNKA P2RY2 SLC22A3 SLC47A1 MEGF11 SLC16A8 | 9.14e-05 | 320 | 119 | 9 | GO:0016323 |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 1.35e-04 | 46 | 119 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | basal plasma membrane | SLC13A3 SLC6A6 SLC10A1 CLCNKA P2RY2 SLC22A3 SLC47A1 MEGF11 SLC16A8 | 1.95e-04 | 354 | 119 | 9 | GO:0009925 |
| GeneOntologyCellularComponent | membrane protein complex | CACNA1A CACNA1B GPR89B CACNA1E MARCHF6 HM13 SYNE4 CHRNA4 CHRNB3 CHRND CHRNE CACNG2 SLC6A6 CLCNKA ABCC8 SCN7A GPR89A SEC63 ATP1A4 ABCG8 | 2.94e-04 | 1498 | 119 | 20 | GO:0098796 |
| GeneOntologyCellularComponent | basal part of cell | SLC13A3 SLC6A6 SLC10A1 CLCNKA P2RY2 SLC22A3 SLC47A1 MEGF11 SLC16A8 | 3.16e-04 | 378 | 119 | 9 | GO:0045178 |
| GeneOntologyCellularComponent | rough endoplasmic reticulum | 4.87e-04 | 64 | 119 | 4 | GO:0005791 | |
| GeneOntologyCellularComponent | postsynaptic membrane | CACNA1A CACNA1E CHRNA4 CRHR1 CHRNB3 CHRND CHRNE CACNG2 SLC6A6 | 5.22e-04 | 405 | 119 | 9 | GO:0045211 |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1A CACNA1B CACNA1E CHRNA4 CHRNB3 CHRND CHRNE CACNG2 SLC6A6 ABCC8 SCN7A ATP1A4 ABCG8 | 5.35e-04 | 785 | 119 | 13 | GO:0098797 |
| GeneOntologyCellularComponent | calcium channel complex | 8.03e-04 | 73 | 119 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | synaptic membrane | CACNA1A CACNA1E CHRNA4 CRHR1 CHRNB3 CHRND CHRNE CACNG2 SLC6A6 P2RY2 | 1.85e-03 | 583 | 119 | 10 | GO:0097060 |
| GeneOntologyCellularComponent | cation channel complex | 2.29e-03 | 235 | 119 | 6 | GO:0034703 | |
| GeneOntologyCellularComponent | ATPase dependent transmembrane transport complex | 3.80e-03 | 55 | 119 | 3 | GO:0098533 | |
| GeneOntologyCellularComponent | side of membrane | FLT3 CD177 CCR9 SPPL3 RAET1E HM13 CHRNA4 CD19 SCART1 CCR4 LY6E KIT | 4.21e-03 | 875 | 119 | 12 | GO:0098552 |
| GeneOntologyCellularComponent | cell surface | TMIGD1 FLT3 DSG2 CCR9 IFITM1 RAET1E HM13 ABCA7 CHRNA4 CACNG2 CD19 SCART1 CCR4 KIT | 4.29e-03 | 1111 | 119 | 14 | GO:0009986 |
| HumanPheno | Drowsiness | 1.19e-05 | 57 | 28 | 5 | HP:0002329 | |
| Domain | GPCR_Rhodpsn_7TM | OR51A4 OR51A2 HCAR2 OR9A4 OR2L3 CCR9 OR2L5 OR13H1 OR5H15 OR5H14 OR2A5 OR10T2 CCKAR CCKBR OR1N2 HCAR3 P2RY2 OR52E8 OR52N5 OR10K1 OR1E1 OR6K3 CCR4 OR6C6 OR5H1 OR9A2 | 1.15e-14 | 670 | 110 | 26 | IPR017452 |
| Domain | 7tm_1 | OR51A4 OR51A2 HCAR2 OR9A4 OR2L3 CCR9 OR2L5 OR13H1 OR5H15 OR5H14 OR2A5 OR10T2 CCKAR CCKBR OR1N2 HCAR3 P2RY2 OR52E8 OR52N5 OR10K1 OR1E1 OR6K3 CCR4 OR6C6 OR5H1 OR9A2 | 1.46e-14 | 677 | 110 | 26 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR51A4 OR51A2 HCAR2 OR9A4 OR2L3 CCR9 OR2L5 OR13H1 OR5H15 OR5H14 OR2A5 OR10T2 CCKAR CCKBR OR1N2 HCAR3 P2RY2 OR52E8 OR52N5 OR10K1 OR1E1 OR6K3 CCR4 OR6C6 OR5H1 OR9A2 | 1.93e-14 | 685 | 110 | 26 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR51A4 OR51A2 HCAR2 OR9A4 OR2L3 CCR9 OR2L5 OR13H1 OR5H15 OR5H14 OR2A5 OR10T2 CCKAR CCKBR OR1N2 HCAR3 P2RY2 OR52E8 OR52N5 OR10K1 OR1E1 OR6K3 CCR4 OR6C6 OR5H1 OR9A2 | 2.36e-14 | 691 | 110 | 26 | PS50262 |
| Domain | GPCR_Rhodpsn | OR51A4 OR51A2 HCAR2 OR9A4 OR2L3 CCR9 OR2L5 OR13H1 OR5H15 OR5H14 OR2A5 OR10T2 CCKAR CCKBR OR1N2 HCAR3 P2RY2 OR52E8 OR52N5 OR10K1 OR1E1 OR6K3 CCR4 OR6C6 OR5H1 OR9A2 | 2.44e-14 | 692 | 110 | 26 | IPR000276 |
| Domain | Olfact_rcpt | OR51A4 OR51A2 OR9A4 OR2L3 OR2L5 OR13H1 OR5H15 OR5H14 OR2A5 OR10T2 OR1N2 OR52E8 OR52N5 OR10K1 OR1E1 OR6K3 OR6C6 OR5H1 OR9A2 | 1.50e-12 | 393 | 110 | 19 | IPR000725 |
| Domain | Nicotinic_acetylcholine_rcpt | 1.96e-06 | 16 | 110 | 4 | IPR002394 | |
| Domain | SNF | 4.12e-06 | 19 | 110 | 4 | PF00209 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 4.12e-06 | 19 | 110 | 4 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 4.12e-06 | 19 | 110 | 4 | PS50267 | |
| Domain | Na/ntran_symport | 4.12e-06 | 19 | 110 | 4 | IPR000175 | |
| Domain | VDCC_a1su_IQ | 6.84e-06 | 7 | 110 | 3 | IPR014873 | |
| Domain | GPHH | 6.84e-06 | 7 | 110 | 3 | PF16905 | |
| Domain | GPHH_dom | 6.84e-06 | 7 | 110 | 3 | IPR031649 | |
| Domain | Ca_chan_IQ | 6.84e-06 | 7 | 110 | 3 | SM01062 | |
| Domain | Ca_chan_IQ | 6.84e-06 | 7 | 110 | 3 | PF08763 | |
| Domain | - | 9.25e-06 | 23 | 110 | 4 | 1.20.120.370 | |
| Domain | Acetylcholine_rcpt_TM | 9.25e-06 | 23 | 110 | 4 | IPR027361 | |
| Domain | VDCCAlpha1 | 2.31e-05 | 10 | 110 | 3 | IPR002077 | |
| Domain | MATE_fam | 3.44e-05 | 2 | 110 | 2 | IPR002528 | |
| Domain | Cholcskin_rcpt | 3.44e-05 | 2 | 110 | 2 | IPR009126 | |
| Domain | MatE | 3.44e-05 | 2 | 110 | 2 | PF01554 | |
| Domain | HCAR2/3_rcpt | 3.44e-05 | 2 | 110 | 2 | IPR028017 | |
| Domain | RSN1_7TM | 1.03e-04 | 3 | 110 | 2 | IPR003864 | |
| Domain | PHM7_cyt | 1.03e-04 | 3 | 110 | 2 | IPR027815 | |
| Domain | PHM7_cyt | 1.03e-04 | 3 | 110 | 2 | PF14703 | |
| Domain | RSN1_7TM | 1.03e-04 | 3 | 110 | 2 | PF02714 | |
| Domain | Csc1_N | 1.03e-04 | 3 | 110 | 2 | IPR032880 | |
| Domain | RSN1_TM | 1.03e-04 | 3 | 110 | 2 | PF13967 | |
| Domain | GPCR_2_CRF_rcpt | 1.03e-04 | 3 | 110 | 2 | IPR003051 | |
| Domain | Neurotransmitter_ion_chnl_CS | 1.41e-04 | 45 | 110 | 4 | IPR018000 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 1.52e-04 | 18 | 110 | 3 | PS00754 | |
| Domain | Neur_chan_memb | 1.54e-04 | 46 | 110 | 4 | PF02932 | |
| Domain | Neur_chan_LBD | 1.67e-04 | 47 | 110 | 4 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 1.67e-04 | 47 | 110 | 4 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 1.67e-04 | 47 | 110 | 4 | IPR006029 | |
| Domain | - | 1.67e-04 | 47 | 110 | 4 | 2.70.170.10 | |
| Domain | Neur_channel | 1.67e-04 | 47 | 110 | 4 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 1.67e-04 | 47 | 110 | 4 | IPR006202 | |
| Domain | Na/ntran_symport_orphan | 3.40e-04 | 5 | 110 | 2 | IPR002438 | |
| Domain | Na/sul_symport | 3.40e-04 | 5 | 110 | 2 | IPR001898 | |
| Domain | Na_sulph_symp | 3.40e-04 | 5 | 110 | 2 | PF00939 | |
| Domain | Peptidase_A22B_SPP | 3.40e-04 | 5 | 110 | 2 | IPR007369 | |
| Domain | Peptidase_A22B | 3.40e-04 | 5 | 110 | 2 | PF04258 | |
| Domain | Channel_four-helix_dom | 3.54e-04 | 57 | 110 | 4 | IPR027359 | |
| Domain | - | 3.54e-04 | 57 | 110 | 4 | 1.20.120.350 | |
| Domain | TAS2R | 4.68e-04 | 26 | 110 | 3 | PF05296 | |
| Domain | T2R | 4.68e-04 | 26 | 110 | 3 | IPR007960 | |
| Domain | Tyr_kinase_CSF1/PDGF_rcpt | 5.08e-04 | 6 | 110 | 2 | IPR016243 | |
| Domain | PSN | 7.08e-04 | 7 | 110 | 2 | SM00730 | |
| Domain | Preselin/SPP | 7.08e-04 | 7 | 110 | 2 | IPR006639 | |
| Domain | Tyr_kinase_rcpt_3_CS | 9.40e-04 | 8 | 110 | 2 | IPR001824 | |
| Domain | RECEPTOR_TYR_KIN_III | 9.40e-04 | 8 | 110 | 2 | PS00240 | |
| Domain | PMP22_Claudin | 1.68e-03 | 40 | 110 | 3 | PF00822 | |
| Domain | RINGv | 1.83e-03 | 11 | 110 | 2 | PF12906 | |
| Domain | ZF_RING_CH | 1.83e-03 | 11 | 110 | 2 | PS51292 | |
| Domain | ABC_transporter_CS | 1.93e-03 | 42 | 110 | 3 | IPR017871 | |
| Domain | PMP22/EMP/MP20/Claudin | 2.36e-03 | 45 | 110 | 3 | IPR004031 | |
| Domain | ABC_tran | 2.84e-03 | 48 | 110 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 2.84e-03 | 48 | 110 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 3.01e-03 | 49 | 110 | 3 | PS00211 | |
| Domain | ABC_transporter-like | 3.19e-03 | 50 | 110 | 3 | IPR003439 | |
| Domain | Chemokine_rcpt | 3.91e-03 | 16 | 110 | 2 | IPR000355 | |
| Domain | 7TM_GPCR_Srsx | 4.34e-03 | 112 | 110 | 4 | SM01381 | |
| Domain | Znf_RING-CH | 4.41e-03 | 17 | 110 | 2 | IPR011016 | |
| Domain | RINGv | 4.41e-03 | 17 | 110 | 2 | SM00744 | |
| Domain | Ion_trans_dom | 4.63e-03 | 114 | 110 | 4 | IPR005821 | |
| Domain | Ion_trans | 4.63e-03 | 114 | 110 | 4 | PF00520 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR51A4 OR51A2 OR9A4 TMC2 OR2L3 OR2L5 OR13H1 OR5H15 OR5H14 OR2A5 APOC2 OR10T2 OR1N2 OR52E8 OR52N5 OR10K1 OR1E1 OR1E3 OR1P1 OR6K3 TAS2R40 TAS2R31 TAS2R43 OR6C6 OR5H1 OR9A2 | 1.19e-14 | 636 | 90 | 26 | M41834 |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR51A4 OR51A2 OR9A4 OR2L3 OR2L5 OR13H1 OR5H15 OR5H14 OR2A5 OR10T2 OR1N2 OR52E8 OR52N5 OR10K1 OR1E1 OR1E3 OR1P1 OR6K3 OR6C6 OR5H1 OR9A2 | 1.23e-13 | 417 | 90 | 21 | M4072 |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | SLC39A3 SLC6A19 SLC6A15 SLC13A3 SLC13A2 SLC47A2 SLC6A6 SLC22A3 SLC47A1 SLC16A8 | 1.26e-10 | 84 | 90 | 10 | M27334 |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | SLC39A3 SLC6A19 SLC6A15 SLC13A3 SLC13A2 SLC6A6 SLC22A3 SLC47A1 SLC16A8 | 1.18e-09 | 76 | 90 | 9 | MM15072 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR51A4 OR51A2 OR9A4 OR2L3 OR13H1 OR2A5 OR10T2 OR1N2 OR52E8 OR52N5 OR10K1 OR1E1 OR6K3 OR6C6 OR9A2 | 2.18e-08 | 389 | 90 | 15 | M14091 |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 4.95e-07 | 11 | 90 | 4 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 4.95e-07 | 11 | 90 | 4 | M26913 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC39A3 SLC6A19 SLC6A15 SLC13A3 SLC13A2 SLC47A2 SLC6A6 SLC20A1 SLC22A3 SLC47A1 SLC16A8 | 5.09e-07 | 249 | 90 | 11 | M5988 |
| Pathway | WP_GPCRS_ODORANT | GPR89B OR5H15 OR5H14 OR1E1 OR1E3 GPR89A TAS2R31 TAS2R43 OR5H1 | 6.85e-07 | 157 | 90 | 9 | MM15872 |
| Pathway | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 7.39e-07 | 12 | 90 | 4 | M48008 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 1.48e-06 | 14 | 90 | 4 | M757 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 2.01e-06 | 15 | 90 | 4 | MM14704 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC39A3 SLC6A19 SLC6A15 SLC13A3 SLC13A2 SLC6A6 SLC20A1 SLC22A3 SLC47A1 SLC16A8 | 2.73e-06 | 238 | 90 | 10 | MM15076 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC39A3 SLC6A19 SLC6A15 SLC13A3 APOC2 SLC13A2 ABCA7 SLC47A2 SLC6A6 CLCNKA SLC20A1 SLC22A3 SLC47A1 ATP1A4 ABCG8 SOAT2 SLC16A8 | 3.43e-06 | 736 | 90 | 17 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC39A3 SLC6A19 SLC6A15 SLC13A3 APOC2 SLC13A2 ABCA7 SLC6A6 CLCNKA SLC20A1 SLC22A3 SLC47A1 ATP1A4 ABCG8 SOAT2 SLC16A8 | 5.60e-06 | 681 | 90 | 16 | MM14985 |
| Pathway | WP_GPCRS_NONODORANT | 7.33e-06 | 266 | 90 | 10 | MM15843 | |
| Pathway | REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS | 8.65e-06 | 7 | 90 | 3 | M27596 | |
| Pathway | REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS | 8.65e-06 | 7 | 90 | 3 | MM15311 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | HCAR2 CCR9 CRHR1 CRHR2 CCKAR CCKBR HCAR3 P2RY2 CCR4 TAS2R40 TAS2R31 TAS2R43 | 1.77e-05 | 430 | 90 | 12 | MM15160 |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.77e-05 | 25 | 90 | 4 | M47948 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 1.95e-05 | 52 | 90 | 5 | M5785 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | HCAR2 CCR9 CRHR1 CRHR2 CCKAR CCKBR HCAR3 P2RY2 CCR4 TAS2R40 TAS2R31 TAS2R43 | 3.66e-05 | 463 | 90 | 12 | M507 |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 4.00e-05 | 11 | 90 | 3 | M47958 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 5.86e-05 | 272 | 90 | 9 | M13380 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 5.97e-05 | 211 | 90 | 8 | MM14502 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.85e-04 | 186 | 90 | 7 | MM15994 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 2.10e-04 | 190 | 90 | 7 | MM15687 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 2.25e-04 | 47 | 90 | 4 | M19708 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 2.26e-04 | 19 | 90 | 3 | M27362 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 2.26e-04 | 19 | 90 | 3 | MM15107 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | CACNA1A CACNA1B CACNA1E CHRNA4 CHRNB3 CHRND CHRNE CACNG2 ABCC8 | 2.83e-04 | 335 | 90 | 9 | MM14503 |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 3.26e-04 | 270 | 90 | 8 | M15514 | |
| Pathway | REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS | 3.98e-04 | 5 | 90 | 2 | MM15099 | |
| Pathway | REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS | 3.98e-04 | 5 | 90 | 2 | M27354 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 4.06e-04 | 23 | 90 | 3 | M47666 | |
| Pathway | WP_PROXIMAL_TUBULE_TRANSPORT | 4.74e-04 | 57 | 90 | 4 | M39812 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | HCAR2 CCR9 CRHR1 CRHR2 CCKAR CCKBR HCAR3 P2RY2 CCR4 TAS2R40 TAS2R31 TAS2R43 | 8.02e-04 | 646 | 90 | 12 | MM14962 |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 9.94e-04 | 31 | 90 | 3 | MM15691 | |
| Pathway | WP_GPCRS_PEPTIDE | 1.03e-03 | 70 | 90 | 4 | MM15959 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 1.09e-03 | 32 | 90 | 3 | MM14957 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.15e-03 | 72 | 90 | 4 | MM14631 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 1.20e-03 | 33 | 90 | 3 | M188 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | CACNA1A CACNA1B CACNA1E CHRNA4 CHRNB3 CHRND CHRNE CACNG2 ABCC8 | 1.22e-03 | 411 | 90 | 9 | M735 |
| Pathway | WP_PEPTIDE_GPCRS | 1.34e-03 | 75 | 90 | 4 | M39696 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.36e-03 | 260 | 90 | 7 | M39397 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.41e-03 | 9 | 90 | 2 | M27597 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.41e-03 | 9 | 90 | 2 | MM15313 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | HCAR2 CCR9 CRHR1 CRHR2 CCKAR CCKBR HCAR3 P2RY2 CCR4 TAS2R40 TAS2R31 TAS2R43 | 1.64e-03 | 702 | 90 | 12 | M746 |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 1.67e-03 | 37 | 90 | 3 | MM15067 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 1.95e-03 | 39 | 90 | 3 | M793 | |
| Pathway | WP_NRF2_PATHWAY | 2.07e-03 | 141 | 90 | 5 | M39454 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 2.14e-03 | 11 | 90 | 2 | M883 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 2.27e-03 | 144 | 90 | 5 | MM14501 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 2.48e-03 | 289 | 90 | 7 | MM15057 | |
| Pathway | WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION | 2.55e-03 | 12 | 90 | 2 | M39802 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 2.55e-03 | 12 | 90 | 2 | MM15312 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 2.76e-03 | 44 | 90 | 3 | M11911 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 3.33e-03 | 47 | 90 | 3 | M42524 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | 3.92e-03 | 314 | 90 | 7 | M39428 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 3.92e-03 | 314 | 90 | 7 | M600 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_BCAP_CD19_PI3K_SIGNALING_PATHWAY | 4.01e-03 | 15 | 90 | 2 | M47971 | |
| Pathway | WP_SYNAPTIC_VESICLE_PATHWAY | 4.20e-03 | 51 | 90 | 3 | M39457 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 5.02e-03 | 108 | 90 | 4 | M17034 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 5.02e-03 | 108 | 90 | 4 | M823 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 5.14e-03 | 330 | 90 | 7 | M18334 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 5.15e-03 | 17 | 90 | 2 | MM14552 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 5.19e-03 | 109 | 90 | 4 | MM15074 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 5.39e-03 | 333 | 90 | 7 | MM14963 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 5.62e-03 | 178 | 90 | 5 | M2890 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 5.77e-03 | 18 | 90 | 2 | M524 | |
| Pathway | WP_GPCRS_ORPHAN | 6.42e-03 | 19 | 90 | 2 | MM15991 | |
| Pathway | WP_CHOLESTASIS | 6.42e-03 | 19 | 90 | 2 | M45520 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 6.93e-03 | 61 | 90 | 3 | MM15071 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR9A4 OR2L3 OR2L5 OR13H1 OR5H15 OR5H14 OR2A5 OR1N2 OR5H8 OR52E8 OR52N5 OR10K1 OR1E1 OR1E3 OR1P1 OR6K3 OR6C6 OR5H1 OR9A2 | 6.75e-18 | 340 | 118 | 19 | 11875048 |
| Pubmed | OR9A4 OR2L3 OR2L5 OR13H1 OR5H15 OR5H14 OR2A5 OR1N2 OR5H8 OR52E8 OR52N5 OR10K1 OR1E1 OR1E3 OR1P1 OR6K3 OR6C6 OR5H1 OR9A2 | 6.75e-18 | 340 | 118 | 19 | 11802173 | |
| Pubmed | OR9A4 OR2L3 OR2L5 OR13H1 OR5H15 OR5H14 OR2A5 OR1N2 OR5H8 OR52E8 OR52N5 OR10K1 OR1E1 OR1E3 OR1P1 OR6K3 OR6C6 OR5H1 OR9A2 | 7.95e-18 | 343 | 118 | 19 | 32295537 | |
| Pubmed | OR9A4 OR2L3 OR2L5 OR13H1 OR5H15 OR5H14 OR2A5 OR1N2 OR5H8 OR52E8 OR52N5 OR10K1 OR1E1 OR1E3 OR1P1 OR6K3 OR6C6 OR5H1 OR9A2 | 9.34e-18 | 346 | 118 | 19 | 14611657 | |
| Pubmed | OR9A4 OR10J6P OR2L5 OR13H1 OR5H14 OR10T2 OR1N2 OR5H8 OR52E8 OR52N5 OR10K1 OR1E1 OR1E3 OR1P1 OR6K3 OR9A2 | 5.11e-11 | 541 | 118 | 16 | 14983052 | |
| Pubmed | 8.72e-09 | 8 | 118 | 4 | 16902085 | ||
| Pubmed | 3.81e-08 | 3 | 118 | 3 | 38996073 | ||
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 3.81e-08 | 3 | 118 | 3 | 24523520 | |
| Pubmed | 1.23e-07 | 14 | 118 | 4 | 19059502 | ||
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 1.52e-07 | 4 | 118 | 3 | 32616470 | |
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 1.52e-07 | 4 | 118 | 3 | 37141091 | |
| Pubmed | Analysis of nicotinic acetylcholine receptor subunits in the cochlea of the mouse. | 1.67e-07 | 15 | 118 | 4 | 8838678 | |
| Pubmed | 2.22e-07 | 16 | 118 | 4 | 19259974 | ||
| Pubmed | 3.79e-07 | 5 | 118 | 3 | 8825650 | ||
| Pubmed | 3.79e-07 | 5 | 118 | 3 | 15451373 | ||
| Pubmed | 3.79e-07 | 5 | 118 | 3 | 11296258 | ||
| Pubmed | 5.06e-07 | 46 | 118 | 5 | 32126975 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 5.10e-07 | 139 | 118 | 7 | 16985003 | |
| Pubmed | An action potential initiation mechanism in distal axons for the control of dopamine release. | 7.56e-07 | 6 | 118 | 3 | 35324301 | |
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 7.56e-07 | 6 | 118 | 3 | 12827191 | |
| Pubmed | 7.56e-07 | 6 | 118 | 3 | 9238069 | ||
| Pubmed | GPR89B TMIGD1 RNASE11 TMC2 CD177 CNPY4 SLC25A14 SPPL3 RAET1E OTOR MFSD2A SIDT2 SLC35F6 GPR89A MEGF11 | 1.30e-06 | 985 | 118 | 15 | 12975309 | |
| Pubmed | Rebuilding essential active zone functions within a synapse. | 1.32e-06 | 7 | 118 | 3 | 35176221 | |
| Pubmed | Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone. | 3.09e-06 | 117 | 118 | 6 | 18996102 | |
| Pubmed | 3.15e-06 | 9 | 118 | 3 | 16382099 | ||
| Pubmed | The human TAS2R16 receptor mediates bitter taste in response to beta-glucopyranosides. | 8.19e-06 | 12 | 118 | 3 | 12379855 | |
| Pubmed | 8.19e-06 | 12 | 118 | 3 | 20584212 | ||
| Pubmed | 9.82e-06 | 143 | 118 | 6 | 20424473 | ||
| Pubmed | Identification and characterization of human taste receptor genes belonging to the TAS2R family. | 1.06e-05 | 13 | 118 | 3 | 12584440 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 12459512 | ||
| Pubmed | Expression and subcellular localization of CRH and its receptors in human endometrial cancer. | 1.14e-05 | 2 | 118 | 2 | 19433256 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 17702579 | ||
| Pubmed | [Regulation of Wnt/beta-catenin signaling by receptor tyrosine kinases in hematological malignancy]. | 1.14e-05 | 2 | 118 | 2 | 19915372 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 28186140 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 19171937 | ||
| Pubmed | Molecular mechanisms of corticotropin-releasing factor receptor-induced calcium signaling. | 1.14e-05 | 2 | 118 | 2 | 19098121 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 30154797 | ||
| Pubmed | The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival. | 1.14e-05 | 2 | 118 | 2 | 24371223 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 20047987 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 9620281 | ||
| Pubmed | Aberrant GABA(A) receptor expression in the dentate gyrus of the epileptic mutant mouse stargazer. | 1.14e-05 | 2 | 118 | 2 | 16914686 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 21774590 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 23043971 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 15610184 | ||
| Pubmed | Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels. | 1.14e-05 | 2 | 118 | 2 | 23426690 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 39083706 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 20594969 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 37543650 | ||
| Pubmed | Neurotransmitter transporters in the central nervous system. | 1.14e-05 | 2 | 118 | 2 | 10471414 | |
| Pubmed | The role of HCA2 (GPR109A) in regulating macrophage function. | 1.14e-05 | 2 | 118 | 2 | 23882124 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 36891315 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 16381801 | ||
| Pubmed | Mechanosensitive channels TMEM63A and TMEM63B mediate lung inflation-induced surfactant secretion. | 1.14e-05 | 2 | 118 | 2 | 38127458 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 26740650 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 36208084 | ||
| Pubmed | Parabacteroides distasonis ameliorates insulin resistance via activation of intestinal GPR109a. | 1.14e-05 | 2 | 118 | 2 | 38007572 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 26656756 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 22467522 | ||
| Pubmed | Detection of KIT and FLT3 mutations in acute myeloid leukemia with different subtypes. | 1.14e-05 | 2 | 118 | 2 | 20039765 | |
| Pubmed | Biased allosteric activation of ketone body receptor HCAR2 suppresses inflammation. | 1.14e-05 | 2 | 118 | 2 | 37597514 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 10670432 | ||
| Pubmed | The Role of GPR109a Signaling in Niacin Induced Effects on Fed and Fasted Hepatic Metabolism. | 1.14e-05 | 2 | 118 | 2 | 33924461 | |
| Pubmed | Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE. | 1.14e-05 | 2 | 118 | 2 | 24691444 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 33977048 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 31347703 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 9216738 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 11745392 | ||
| Pubmed | Loss of GPR109A/HCAR2 induces aging-associated hepatic steatosis. | 1.14e-05 | 2 | 118 | 2 | 30659164 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 11112352 | ||
| Pubmed | Expression of cholecystokinin receptors in colon cancer and the clinical correlation in Taiwan. | 1.14e-05 | 2 | 118 | 2 | 26508021 | |
| Pubmed | Niacin-induced hyperglycemia is partially mediated via niacin receptor GPR109a in pancreatic islets. | 1.14e-05 | 2 | 118 | 2 | 25622782 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 8343165 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 23740774 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 23038256 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 8500431 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 33420329 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 19223991 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 31844086 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 30433870 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 12646212 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 7621074 | ||
| Pubmed | PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. | 1.14e-05 | 2 | 118 | 2 | 12563315 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 32439173 | ||
| Pubmed | Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3. | 1.14e-05 | 2 | 118 | 2 | 19540337 | |
| Pubmed | Niacin increases adiponectin and decreases adipose tissue inflammation in high fat diet-fed mice. | 1.14e-05 | 2 | 118 | 2 | 23967184 | |
| Pubmed | The Role of Cholecystokinin in Peripheral Taste Signaling in Mice. | 1.14e-05 | 2 | 118 | 2 | 29163209 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 26608796 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 17170072 | ||
| Pubmed | A human transporter protein that mediates the final excretion step for toxic organic cations. | 1.14e-05 | 2 | 118 | 2 | 16330770 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 26371038 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 14724656 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 34653248 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 19136666 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 22572823 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 33488584 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 14534299 | ||
| Pubmed | Lactate-induced activation of HCA2 improves survival in mice with sepsis. | 1.14e-05 | 2 | 118 | 2 | 30951370 | |
| Pubmed | Receptor kinase profiles identify a rationale for multitarget kinase inhibition in immature T-ALL. | 1.14e-05 | 2 | 118 | 2 | 22751451 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 23376566 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 17959885 | ||
| Interaction | SPPL2B interactions | SPPL3 TMEM63B IFITM1 SYNE4 CHRNA4 CHRND CHRNE SIDT2 ADIPOR1 GPR89A | 1.36e-07 | 233 | 94 | 10 | int:SPPL2B |
| Interaction | GPR21 interactions | 2.15e-06 | 81 | 94 | 6 | int:GPR21 | |
| Interaction | TMEM17 interactions | DSG2 SLC6A15 LBR HM13 SLC6A6 FAM171A1 ADIPOR1 SLC20A1 GPR89A TRIM13 SEC63 | 2.85e-06 | 404 | 94 | 11 | int:TMEM17 |
| Interaction | GPR12 interactions | 4.82e-06 | 93 | 94 | 6 | int:GPR12 | |
| Interaction | POMT2 interactions | 8.84e-06 | 60 | 94 | 5 | int:POMT2 | |
| Interaction | TUSC3 interactions | 9.60e-06 | 61 | 94 | 5 | int:TUSC3 | |
| Interaction | HTR3A interactions | 1.14e-05 | 108 | 94 | 6 | int:HTR3A | |
| Interaction | TCTN2 interactions | 1.24e-05 | 304 | 94 | 9 | int:TCTN2 | |
| Interaction | LRRC55 interactions | 1.42e-05 | 66 | 94 | 5 | int:LRRC55 | |
| Interaction | SIDT2 interactions | 4.98e-05 | 140 | 94 | 6 | int:SIDT2 | |
| Interaction | CCKAR interactions | 6.44e-05 | 3 | 94 | 2 | int:CCKAR | |
| Interaction | TMEM63B interactions | 6.53e-05 | 147 | 94 | 6 | int:TMEM63B | |
| Interaction | ZDHHC9 interactions | 8.01e-05 | 49 | 94 | 4 | int:ZDHHC9 | |
| Interaction | TTYH1 interactions | 8.07e-05 | 300 | 94 | 8 | int:TTYH1 | |
| Interaction | CCKBR interactions | 1.06e-04 | 20 | 94 | 3 | int:CCKBR | |
| Interaction | TM2D2 interactions | 1.23e-04 | 21 | 94 | 3 | int:TM2D2 | |
| Interaction | ABCG5 interactions | 1.28e-04 | 4 | 94 | 2 | int:ABCG5 | |
| Interaction | TMEM216 interactions | 1.54e-04 | 246 | 94 | 7 | int:TMEM216 | |
| Interaction | TMPRSS12 interactions | 1.63e-04 | 23 | 94 | 3 | int:TMPRSS12 | |
| Interaction | ERGIC3 interactions | 1.91e-04 | 340 | 94 | 8 | int:ERGIC3 | |
| Interaction | PLPPR3 interactions | 2.36e-04 | 26 | 94 | 3 | int:PLPPR3 | |
| Interaction | NKAIN1 interactions | 2.42e-04 | 65 | 94 | 4 | int:NKAIN1 | |
| Interaction | GABRA3 interactions | 2.96e-04 | 28 | 94 | 3 | int:GABRA3 | |
| Interaction | KLRK1 interactions | 2.96e-04 | 28 | 94 | 3 | int:KLRK1 | |
| Interaction | UCN interactions | 3.19e-04 | 6 | 94 | 2 | int:UCN | |
| Interaction | CHRND interactions | 3.22e-04 | 70 | 94 | 4 | int:CHRND | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q11 | 1.23e-05 | 54 | 119 | 4 | chr3q11 | |
| Cytoband | 3q12.1 | 2.18e-05 | 21 | 119 | 3 | 3q12.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q23 | 2.91e-05 | 226 | 119 | 6 | chr1q23 | |
| Cytoband | 11p15.4 | 1.82e-04 | 200 | 119 | 5 | 11p15.4 | |
| Cytoband | 1q23.1 | 2.38e-04 | 46 | 119 | 3 | 1q23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 6.97e-04 | 564 | 119 | 7 | chr11p15 | |
| Cytoband | 12q24.31 | 1.21e-03 | 80 | 119 | 3 | 12q24.31 | |
| Cytoband | 17p13.3 | 1.59e-03 | 88 | 119 | 3 | 17p13.3 | |
| Cytoband | 1q23.2 | 3.75e-03 | 35 | 119 | 2 | 1q23.2 | |
| GeneFamily | Solute carriers | SLC39A3 SLC6A16 SLC25A14 SLC6A19 SLC6A15 SLC13A3 SLC13A2 SLC47A2 SLC6A6 SLC10A1 SLC20A1 SLC22A3 SLC47A1 SLC16A8 | 1.20e-08 | 395 | 92 | 14 | 752 |
| GeneFamily | Cholinergic receptors nicotinic subunits | 1.09e-06 | 16 | 92 | 4 | 173 | |
| GeneFamily | Calcium voltage-gated channel subunits | 8.61e-06 | 26 | 92 | 4 | 253 | |
| GeneFamily | Corticotropin releasing hormone receptors | 2.56e-05 | 2 | 92 | 2 | 266 | |
| GeneFamily | Cholecystokinin receptors | 2.56e-05 | 2 | 92 | 2 | 224 | |
| GeneFamily | Olfactory receptors, family 1 | 4.99e-05 | 40 | 92 | 4 | 147 | |
| GeneFamily | Hydroxy-carboxylic acid receptors | 7.66e-05 | 3 | 92 | 2 | 200 | |
| GeneFamily | Taste 2 receptors | 1.02e-03 | 39 | 92 | 3 | 1162 | |
| GeneFamily | CD molecules|C-C motif chemokine receptors | 1.12e-03 | 10 | 92 | 2 | 1091 | |
| GeneFamily | Ring finger proteins|Membrane associated ring-CH-type fingers | 1.37e-03 | 11 | 92 | 2 | 60 | |
| GeneFamily | Olfactory receptors, family 5 | 2.57e-03 | 112 | 92 | 4 | 152 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.96e-03 | 394 | 92 | 7 | 471 | |
| GeneFamily | Olfactory receptors, family 10 | 4.63e-03 | 66 | 92 | 3 | 157 | |
| GeneFamily | Olfactory receptors, family 9 | 6.04e-03 | 23 | 92 | 2 | 156 | |
| GeneFamily | CD molecules|Complement system|LY6/PLAUR domain containing | 1.29e-02 | 34 | 92 | 2 | 1226 | |
| GeneFamily | Immunoglobulin like domain containing | 1.70e-02 | 193 | 92 | 4 | 594 | |
| GeneFamily | MAGE family | 1.76e-02 | 40 | 92 | 2 | 1136 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.76e-02 | 40 | 92 | 2 | 321 | |
| GeneFamily | Olfactory receptors, family 2 | 2.00e-02 | 113 | 92 | 3 | 149 | |
| GeneFamily | Olfactory receptors, family 51 | 2.11e-02 | 44 | 92 | 2 | 164 | |
| ToppCell | severe_COVID-19-Neutrophil|World / disease group, cell group and cell class (v2) | 3.20e-07 | 170 | 116 | 7 | dfc807e0dd66179490a258ecbe8eb439e715799d | |
| ToppCell | severe_COVID-19-Neutrophil|severe_COVID-19 / disease group, cell group and cell class (v2) | 3.47e-07 | 172 | 116 | 7 | 8f4bcb9b2bbf8b4333f673d8ad6bb88dfda4792a | |
| ToppCell | 3'-Adult-SmallIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.64e-07 | 197 | 116 | 7 | 1614bc5f41fd2c8385e58ed6b87ef1536421f29a | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.40e-06 | 174 | 116 | 6 | 3503c7dec498597f76a86dbd5e4bb2311e743bde | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.06e-06 | 177 | 116 | 6 | 43dce527392f3b8364bb6a55268ce9d6518d3a29 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-06 | 179 | 116 | 6 | d1ef7e1cb00336118e387b47f4f8120f53584391 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.81e-06 | 184 | 116 | 6 | ed7a8e79e5723a5f5a03f542203d9e50bdef5f50 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.37e-06 | 186 | 116 | 6 | bdd9d3a432aab46e733469b362f0064d35c1ac49 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.66e-06 | 187 | 116 | 6 | 9042bd0f57213a51503d9df2e4dce3209b7772d3 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-05 | 192 | 116 | 6 | 4a2c82e7af700ae6f04742027877768b151f5d81 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-05 | 194 | 116 | 6 | 64e07de047969017628a164b254852c87d33844c | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.38e-05 | 199 | 116 | 6 | 7ebd89dff457f57a549eecee288c7a4b515b4018 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_dendritic-CD141-positive_myeloid_dendritic_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.78e-05 | 144 | 116 | 5 | a9305d2499189f23b942775285be9fb260ce4214 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-05 | 157 | 116 | 5 | 3cffedafff31efb5b3259194157b54a768367459 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-05 | 157 | 116 | 5 | f87e867a394b0453ebd92c592e80450caf5902cb | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-05 | 158 | 116 | 5 | e1a8dba5a88bc3ce112829c5ecb112cbbee5b078 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-05 | 158 | 116 | 5 | 72e4f8ae137a7dddee0dc6236532e0711065e6af | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-neutrophil-neutrophil|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.05e-05 | 159 | 116 | 5 | be54b910ccb73e37eb81945bbad9a89d2bcec34b | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-neutrophil|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.05e-05 | 159 | 116 | 5 | 178678173b005cb8225472306657f0d8289b133b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.23e-05 | 160 | 116 | 5 | 174a4ab27114efcc63be36929b80680be3c35c9b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.23e-05 | 160 | 116 | 5 | 1e210e526ea4d84fc58a798a26c0929bcb69fd89 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-05 | 162 | 116 | 5 | dddf7a3901ae59e3494d8a6740db0fa15cc96d47 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-05 | 162 | 116 | 5 | 2a4e09545e9874519f0f56e81065104987d81cd6 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-05 | 162 | 116 | 5 | 922ecea81063095b8dd9ac9f9792bf551edbb848 | |
| ToppCell | Club-club-12|World / Class top | 7.21e-05 | 165 | 116 | 5 | 9b7a31cbdcd2f96b8bd08a4cd4141b92bd5e9062 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-05 | 165 | 116 | 5 | 4fe7c3c9370a556cf4e308a2e723b4b907a6cc25 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-05 | 166 | 116 | 5 | aa2df07eff323ded751ced8938af08223d7f2029 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-05 | 166 | 116 | 5 | 695298a94d62b8adab083900003ec636fbaae5d9 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-05 | 166 | 116 | 5 | b7f303203068b205f382788815df487a0ea148ed | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.63e-05 | 167 | 116 | 5 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | Influenza_Severe-Neutrophil|World / Disease group and Cell class | 8.07e-05 | 169 | 116 | 5 | 6e8e2580e19c96bcf7fa6a6d8c183df65f428396 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.07e-05 | 169 | 116 | 5 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | Mild-Treg|World / Disease group and Cell class | 8.30e-05 | 170 | 116 | 5 | f3f177534badca34e1ae8671b7f583ee6688e14b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.53e-05 | 171 | 116 | 5 | f5014e3c387fe3118944af392abe10d6b9b0abab | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.01e-05 | 173 | 116 | 5 | e05cddf5bf63cf419343ff229453327519765be8 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.01e-05 | 173 | 116 | 5 | 5b76d9cc56bbb29017e64a2d0a3c76c0be003d96 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.01e-05 | 173 | 116 | 5 | bf685025961e79b379f2c35464b6c8ce3e31ace0 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.01e-05 | 173 | 116 | 5 | a6e73a40b0d5356564a594053e772f9d061a5919 | |
| ToppCell | severe_influenza-Neutrophil|severe_influenza / disease group, cell group and cell class (v2) | 9.01e-05 | 173 | 116 | 5 | 615e266419b9f06e964eff73cb466f05451ba0dd | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.01e-05 | 173 | 116 | 5 | a8b5370f4c893a20c58e97659f3ac168699693f8 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.01e-05 | 173 | 116 | 5 | 74ad5ed33821b8816c9c8e67c50ee4496ba18e2f | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.01e-05 | 173 | 116 | 5 | 1edef5aeab626cbf2c09468e77b02cfa2d21ba03 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.01e-05 | 173 | 116 | 5 | c37dba3804df7c3151e18e6ae4e0b6e7a92bae97 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.01e-05 | 173 | 116 | 5 | 8888434641ea554a9b62c436e87920378eef29cd | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.03e-04 | 178 | 116 | 5 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | Severe-Myeloid-Neutrophil|Severe / Condition, Lineage, Cell class and cell subclass | 1.03e-04 | 178 | 116 | 5 | 454313efe59d71e7327b9758efabf2d893e4a8fd | |
| ToppCell | Severe-Myeloid-Neutrophil-|Severe / Condition, Lineage, Cell class and cell subclass | 1.03e-04 | 178 | 116 | 5 | 8618ae891d62bf70fe860ff7bb2d31868961aa13 | |
| ToppCell | Mild-Treg|Mild / Disease group and Cell class | 1.03e-04 | 178 | 116 | 5 | e669fd95278e145f55126d0e6be8fb2d6184dbbd | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-04 | 179 | 116 | 5 | adf8b025032a03dbb58871a92025cd7efbeb22ff | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 179 | 116 | 5 | 78fae47ec9bff4e0159a86a281e831d7f8ee925a | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.06e-04 | 179 | 116 | 5 | af0b54c9ea0b6e4210f22dbb6e88ecd3276a5f86 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.09e-04 | 180 | 116 | 5 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.09e-04 | 180 | 116 | 5 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.11e-04 | 181 | 116 | 5 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 183 | 116 | 5 | ee9c88be88221b7ad4ea9f890b17d6156fb3432e | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 183 | 116 | 5 | c52b84034503d931f7b87312d2ff86daff14152d | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.23e-04 | 185 | 116 | 5 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-ILC3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.27e-04 | 186 | 116 | 5 | ac1d2a94674bd15885e70502abad3a2ff3c21d73 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 186 | 116 | 5 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 187 | 116 | 5 | 1b82920588f9e26ef1db244d452736d75fcfd342 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-ILC3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.30e-04 | 187 | 116 | 5 | a037631a01d2cce088e6522dceeb1eee806522a1 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-04 | 187 | 116 | 5 | 11670a85db87cbb3e78022a589632173604b0940 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 187 | 116 | 5 | c1e4c0345f9bfa0538730bad5ff3fa5240168b25 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-04 | 187 | 116 | 5 | 0277d4e54bd4d48f30241c2951a569209423fee8 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_granulocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.33e-04 | 188 | 116 | 5 | 36ff615154d6d9e3ba6ccb73a0f11574bcbf5ece | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.33e-04 | 188 | 116 | 5 | bd091503f580dedab40e0996273101285d24b586 | |
| ToppCell | (7)_Epithelial-D_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.40e-04 | 190 | 116 | 5 | 832d6d3ad14665e50623afe1b8586ccae1a97de5 | |
| ToppCell | droplet-Fat-Scat-18m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 192 | 116 | 5 | 4098b5170c9995718758a082d1b8bcb86d5a289e | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-ILC2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.47e-04 | 192 | 116 | 5 | 017f613b1b9c0bd0842e5c1e71d3ac60dd89eadd | |
| ToppCell | droplet-Fat-Scat-18m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 192 | 116 | 5 | 936028fe851e8dd2b906df0210acc574c017b499 | |
| ToppCell | droplet-Fat-Scat-18m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 192 | 116 | 5 | 62e55ed0d46b2e7b07dc42399972a099576cbc5f | |
| ToppCell | (7)_Epithelial-C_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.50e-04 | 193 | 116 | 5 | a3ca6ab20c8de260e410ddc14d3d202f28b9d6c2 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 194 | 116 | 5 | 0ef63abcfd057079a9a6f8b27404ff521d44845d | |
| ToppCell | (7)_Epithelial_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.54e-04 | 194 | 116 | 5 | 413e8b9f1e15be363a7f4a8f727af3eeb9e9a928 | |
| ToppCell | AT2|World / shred by cell class for parenchyma | 1.54e-04 | 194 | 116 | 5 | e773f5ef3abce7113a6b7cc7cbe68de873d4a17f | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 1.58e-04 | 195 | 116 | 5 | 1992a1673b7213e25f3c76ac77da35c57daceddd | |
| ToppCell | droplet-Mammary_Gland-nan-18m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 195 | 116 | 5 | c771ac1db8bd5f3a80bd3484094a58c28983f97b | |
| ToppCell | 390C-Epithelial_cells-Epithelial-C_(AT2)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.58e-04 | 195 | 116 | 5 | d0608db4a61576e67f4a3a52e1f84d788a1dea85 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-C_(AT2)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.58e-04 | 195 | 116 | 5 | bdfe486d32cb598950c1a5f5cdab40302c8f0f99 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.58e-04 | 195 | 116 | 5 | 5a6a5048af638872700b76b7c71a8fa3fb8d3772 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-04 | 196 | 116 | 5 | 4deaadb9796b907b7480fb7af5ed76ebad240850 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 196 | 116 | 5 | 4ebcaac758ed01d918de9c1cd383a84457b615f3 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-B_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.66e-04 | 197 | 116 | 5 | 06ed8f293d4ee89f14dc2f43d6cae93bbc02508a | |
| ToppCell | Enterocyte|World / shred on cell type and cluster | 1.66e-04 | 197 | 116 | 5 | 1dd980fd066aef21694395a4b69df938501d9631 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-B_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.66e-04 | 197 | 116 | 5 | c115d0a45545ed24259ad88872231bf4d4d389d2 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-04 | 197 | 116 | 5 | f097e729f515e7945b9482e9f9dbc9536b90f0bb | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-04 | 198 | 116 | 5 | e3e2233c796d5e9051c8c1b66f70f406f048ed56 | |
| ToppCell | C_01|World / shred on cell type and cluster | 1.69e-04 | 198 | 116 | 5 | 71d38084d09a96331877384ce6346f0de4bdcef9 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-04 | 198 | 116 | 5 | 8e640e7b464c72ee41402f31dcc3b0032bdab277 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-04 | 198 | 116 | 5 | cc162ba4b3b8dec667a8cffd3411965f3f856f8c | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-04 | 106 | 116 | 4 | d8868c10785e52a1c22c91e1d0e208f2070393bb | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-04 | 199 | 116 | 5 | 043c65bdf54a1bf0e483fea9ffc042ff5b271764 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-04 | 199 | 116 | 5 | 7540973d36f78cd9f13210635ff0708d20c8b209 | |
| ToppCell | 5'-Adult-SmallIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-04 | 199 | 116 | 5 | a5fffe381be1ba7d192b68d1d3937ce47663658e | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.73e-04 | 199 | 116 | 5 | f8846446ebbc4948cdc69640782db1358bbdc486 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-04 | 199 | 116 | 5 | 2f6cb5c9f08fc1b6b7771a0360c93a69a7319f13 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-04 | 199 | 116 | 5 | ab71b312635a2b2c98d71b60a299f44bc80a3587 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.73e-04 | 199 | 116 | 5 | fe9f5bc317be0c35bd96311bf0b3c7b91d98acc5 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar-AT2|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-04 | 199 | 116 | 5 | fa5ddba3ac1ebe712cd4cdc3f20339f7c715d039 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.73e-04 | 199 | 116 | 5 | 3e35ee426ef06f9af568c37349b62dd1ee9b97ea | |
| Computational | Membranal receptors. | FLT3 CCR9 IFITM1 SLC13A2 CHRNA4 CRHR2 CCKAR CHRNB3 CCKBR CHRND CHRNE HCAR3 SLC10A1 CD19 CLCNKA SCN7A LY6E KIT | 1.06e-10 | 517 | 58 | 18 | MODULE_64 |
| Computational | Genes in the cancer module 267. | 6.48e-05 | 15 | 58 | 3 | MODULE_267 | |
| Computational | Peptide and AA transporters. | 1.15e-04 | 18 | 58 | 3 | MODULE_368 | |
| Computational | Porins / transporters. | 1.31e-04 | 211 | 58 | 7 | MODULE_63 | |
| Computational | Genes in the cancer module 218. | 1.59e-04 | 20 | 58 | 3 | MODULE_218 | |
| Computational | Genes in the cancer module 71. | 2.13e-04 | 22 | 58 | 3 | MODULE_71 | |
| Computational | Ion channels. | 3.98e-04 | 27 | 58 | 3 | MODULE_214 | |
| Computational | Genes in the cancer module 12. | PIGB SLC13A2 CRHR2 CCKAR CHRNE SLC6A6 CD19 CLCNKA ABCC8 LY6E | 4.06e-04 | 519 | 58 | 10 | MODULE_13 |
| Computational | Ion channels. | 5.37e-04 | 70 | 58 | 4 | MODULE_316 | |
| Drug | alpha-conotoxin SI | 1.32e-13 | 23 | 113 | 8 | CID000163979 | |
| Drug | nefiracetam | CACNA1A CACNA1B CACNA1E HCAR2 CHRNA4 CHRNB3 CHRND CHRNE HCAR3 | 8.24e-12 | 56 | 113 | 9 | CID000071157 |
| Drug | ABT-418 | 1.41e-11 | 23 | 113 | 7 | CID000119380 | |
| Drug | procaine | CACNA1A CACNA1B CACNA1E HCAR2 CHRNA4 CHRNB3 CHRND CHRNE CACNG2 HCAR3 SCN7A | 2.84e-10 | 153 | 113 | 11 | CID000004914 |
| Drug | NSC-293162 | 6.83e-10 | 38 | 113 | 7 | CID000004675 | |
| Drug | Skpymrfamide | 1.23e-09 | 23 | 113 | 6 | CID000132661 | |
| Drug | disopyramide | 1.29e-09 | 66 | 113 | 8 | CID000003114 | |
| Drug | procyclidine | 1.64e-09 | 24 | 113 | 6 | CID000004919 | |
| Drug | atropine sulfate | CACNA1B CACNA1E HCAR2 CHRNA4 CRHR1 CRHR2 CCKAR CHRNB3 CCKBR CHRND CHRNE HCAR3 CLCNKA ABCC8 | 1.98e-09 | 347 | 113 | 14 | CID000003661 |
| Drug | beta-eudesmol | 2.78e-09 | 26 | 113 | 6 | CID000091457 | |
| Drug | pilsicainide | 2.80e-09 | 46 | 113 | 7 | CID000004820 | |
| Drug | nicardipine | CACNA1A CACNA1B CACNA1E HCAR2 CHRNA4 CHRNB3 CHRND CHRNE CACNG2 HCAR3 | 2.85e-09 | 145 | 113 | 10 | CID000004473 |
| Drug | hemicholinium-3 | 5.03e-09 | 78 | 113 | 8 | CID000003585 | |
| Drug | (-)-pictamine | 7.95e-09 | 15 | 113 | 5 | CID006918623 | |
| Drug | (-)-lepadin B | 7.95e-09 | 15 | 113 | 5 | CID006918624 | |
| Drug | UB-165 | 7.95e-09 | 15 | 113 | 5 | CID004694339 | |
| Drug | tropicamide | 1.07e-08 | 32 | 113 | 6 | CID000005593 | |
| Drug | brimonidine | 1.10e-08 | 86 | 113 | 8 | CID000002435 | |
| Drug | AC1L2SVN | 1.15e-08 | 16 | 113 | 5 | CID000127922 | |
| Drug | decamethonium | 1.30e-08 | 33 | 113 | 6 | CID000002968 | |
| Drug | cytisine | 1.30e-08 | 33 | 113 | 6 | CID000010235 | |
| Drug | bethanechol | 1.58e-08 | 90 | 113 | 8 | CID000002370 | |
| Drug | (+/-)-Epibatidine | 1.89e-08 | 35 | 113 | 6 | CID000001204 | |
| Drug | verapamil | CACNA1A CACNA1B CACNA1E HCAR2 APOC2 ABCA7 CHRNA4 CHRNB3 CHRND CHRNE CACNG2 HCAR3 SLC22A3 SCN7A ABCG8 | 2.09e-08 | 490 | 113 | 15 | CID000002520 |
| Drug | ABT-594 | 2.24e-08 | 18 | 113 | 5 | CID003075702 | |
| Drug | AC1LCVGE | 2.24e-08 | 18 | 113 | 5 | CID000656712 | |
| Drug | NSC7524 | CACNA1A CACNA1B CACNA1E HCAR2 CHRNA4 CHRNB3 CHRNE CACNG2 HCAR3 SCN7A | 2.53e-08 | 182 | 113 | 10 | CID000005657 |
| Drug | succinylcholine | 3.02e-08 | 64 | 113 | 7 | CID000005314 | |
| Drug | AC1L9P88 | 3.03e-08 | 19 | 113 | 5 | CID000450860 | |
| Drug | isoarecolone | 3.03e-08 | 19 | 113 | 5 | CID000146970 | |
| Drug | beta-erythroidine | 3.03e-08 | 19 | 113 | 5 | CID000010074 | |
| Drug | perhydrohistrionicotoxin | 3.03e-08 | 19 | 113 | 5 | CID000107881 | |
| Drug | 4-(N-maleimido)benzyltrimethylammonium | 3.03e-08 | 19 | 113 | 5 | CID000162425 | |
| Drug | 3-(2-azetidinylmethoxy)pyridine | 4.02e-08 | 20 | 113 | 5 | CID000001962 | |
| Drug | hexamethonium | 4.05e-08 | 143 | 113 | 9 | CID000003604 | |
| Drug | 4-dideoxy-1,4-imino-D-xylitol | CACNA1A CACNA1B CACNA1E HCAR2 CHRNA4 CRHR1 CCKAR CHRNB3 CHRNE HCAR3 | 5.11e-08 | 196 | 113 | 10 | CID000001335 |
| Drug | dinotefuran | 5.26e-08 | 21 | 113 | 5 | CID000197701 | |
| Drug | meproadifen | 5.26e-08 | 21 | 113 | 5 | CID000189752 | |
| Drug | halothane | CACNA1A CACNA1B CACNA1E HCAR2 APOC2 LBR CHRNA4 CHRNB3 CHRND CHRNE CACNG2 HCAR3 | 5.47e-08 | 314 | 113 | 12 | CID000003562 |
| Drug | N-methylscopolamine | 5.93e-08 | 42 | 113 | 6 | CID000004120 | |
| Drug | AR-R17779 | 6.78e-08 | 22 | 113 | 5 | CID005310971 | |
| Drug | histrionicotoxin | 6.78e-08 | 22 | 113 | 5 | CID005282247 | |
| Drug | clothianidin | 6.78e-08 | 22 | 113 | 5 | CID000213027 | |
| Drug | gallamin | 6.86e-08 | 43 | 113 | 6 | CID000067425 | |
| Drug | dihydro-beta-erythroidine | 7.91e-08 | 44 | 113 | 6 | CID000031762 | |
| Drug | NSC100058 | 8.41e-08 | 74 | 113 | 7 | CID000003449 | |
| Drug | AC1L3BL8 | 8.63e-08 | 23 | 113 | 5 | CID000086457 | |
| Drug | alpha-conotoxin ImI | 8.63e-08 | 23 | 113 | 5 | CID000133011 | |
| Drug | CID6325740 | 8.63e-08 | 23 | 113 | 5 | CID006325740 | |
| Drug | 3H-diazirine | 9.09e-08 | 45 | 113 | 6 | CID000078958 | |
| Drug | guanethidine | 9.51e-08 | 113 | 113 | 8 | CID000003518 | |
| Drug | gamma-aminobutyric acid | CACNA1A CACNA1B CACNA1E HCAR2 SLC6A15 APOC2 CHRNA4 CHRNB3 CCKBR CHRNE CACNG2 SLC6A6 HCAR3 CLCNKA | 9.93e-08 | 474 | 113 | 14 | CID000000119 |
| Drug | ipratropium bromide | 1.04e-07 | 46 | 113 | 6 | CID000003746 | |
| Drug | intruder | 1.09e-07 | 24 | 113 | 5 | CID000213021 | |
| Drug | anabaseine | 1.09e-07 | 24 | 113 | 5 | CID000018985 | |
| Drug | anabasine | 1.35e-07 | 25 | 113 | 5 | CID000002181 | |
| Drug | varenicline | 1.35e-07 | 25 | 113 | 5 | CID000170361 | |
| Drug | pempidine | 1.35e-07 | 25 | 113 | 5 | CID000006603 | |
| Drug | edrophonium | 1.35e-07 | 48 | 113 | 6 | CID000003202 | |
| Drug | NSC755875 | 1.39e-07 | 165 | 113 | 9 | CID000002215 | |
| Drug | EN-1530 | HCAR2 LBR CHRNA4 CRHR1 CRHR2 CCKAR CHRNB3 CCKBR CHRNE HCAR3 TRIM13 | 1.43e-07 | 278 | 113 | 11 | CID000004425 |
| Drug | benzquinamide | 1.67e-07 | 26 | 113 | 5 | CID000002342 | |
| Drug | curarine | 1.67e-07 | 26 | 113 | 5 | CID000198004 | |
| Drug | McN-A-343 | 1.74e-07 | 50 | 113 | 6 | CID000004022 | |
| Drug | sodium | GPR89B HCAR2 TIMD4 SLC6A16 SLC6A15 SLC13A3 SLC13A2 CHRNA4 CHRNE SLC6A6 HCAR3 SLC10A1 CLCNKA P2RY2 SLC20A1 SLC22A3 SCN7A SLC47A1 ATP1A4 | 1.92e-07 | 944 | 113 | 19 | CID000000923 |
| Drug | methylcarbamylcholine | 2.04e-07 | 27 | 113 | 5 | CID000004136 | |
| Drug | nornicotine | 2.04e-07 | 27 | 113 | 5 | CID000000412 | |
| Drug | ethidium bromide | 2.21e-07 | 85 | 113 | 7 | CID000003624 | |
| Drug | tetramethylammonium | 2.48e-07 | 53 | 113 | 6 | CID000006380 | |
| Drug | bifemelane | 2.97e-07 | 29 | 113 | 5 | CID000002377 | |
| Drug | bromoacetylcholine bromide | 2.97e-07 | 29 | 113 | 5 | CID000204966 | |
| Drug | NSC624746 | 3.86e-07 | 57 | 113 | 6 | CID000107640 | |
| Drug | tetrahydrodeoxycortisol | 4.22e-07 | 31 | 113 | 5 | CID000010593 | |
| Drug | AC1L1JK6 | 4.22e-07 | 31 | 113 | 5 | CID000005077 | |
| Drug | procainamide | 4.59e-07 | 190 | 113 | 9 | CID000004913 | |
| Drug | AC 110 | 4.74e-07 | 4 | 113 | 3 | CID000022860 | |
| Drug | dimethylphenylpiperazinium | 4.75e-07 | 59 | 113 | 6 | CID000001316 | |
| Drug | benzodiazepine | 5.54e-07 | 142 | 113 | 8 | CID000134664 | |
| Drug | otenzepad | 5.81e-07 | 61 | 113 | 6 | CID000107867 | |
| Drug | methamidophos | 5.85e-07 | 33 | 113 | 5 | CID000004096 | |
| Drug | muscarine | 6.16e-07 | 144 | 113 | 8 | CID000009308 | |
| Drug | GTS-21 | 6.83e-07 | 34 | 113 | 5 | CID005310985 | |
| Drug | thiacloprid | 6.83e-07 | 34 | 113 | 5 | CID000115224 | |
| Drug | l-Lobeline | 6.83e-07 | 34 | 113 | 5 | CID000003945 | |
| Drug | methoctramine | 7.06e-07 | 63 | 113 | 6 | CID000004108 | |
| Drug | ivermectin | 7.20e-07 | 101 | 113 | 7 | CID006435110 | |
| Drug | atracurium | 7.94e-07 | 35 | 113 | 5 | CID000047319 | |
| Drug | EPTC | 7.94e-07 | 35 | 113 | 5 | CID000012968 | |
| Drug | 4-DAMP | 8.51e-07 | 65 | 113 | 6 | CID000001734 | |
| Drug | pseudococaine | HCAR2 SLC6A16 CCR9 OR10T2 CHRNA4 CRHR1 CRHR2 CHRNB3 CHRND CHRNE HCAR3 SCN7A CCR4 SOAT2 | 9.15e-07 | 570 | 113 | 14 | CID000002826 |
| Drug | PhTX-343 | 9.18e-07 | 36 | 113 | 5 | CID000159548 | |
| Drug | O585 | 1.06e-06 | 37 | 113 | 5 | CID000107646 | |
| Drug | AC1NSKJI | 1.11e-06 | 68 | 113 | 6 | CID005311391 | |
| Drug | oxotremorine | 1.13e-06 | 108 | 113 | 7 | CID000004630 | |
| Drug | 3,4-diaminopyridine | 1.21e-06 | 38 | 113 | 5 | CID000005918 | |
| Drug | tetradotoxin | CACNA1A CACNA1B CACNA1E HCAR2 CHRNA4 CCKAR CHRNB3 CCKBR CHRND CHRNE HCAR3 SCN7A | 1.49e-06 | 428 | 113 | 12 | CID000020382 |
| Drug | quindine | 1.50e-06 | 219 | 113 | 9 | CID000001065 | |
| Drug | arecoline | 1.56e-06 | 72 | 113 | 6 | CID000002230 | |
| Drug | Tubocurarine,d | 1.56e-06 | 72 | 113 | 6 | CID000001210 | |
| Drug | carbachol | CACNA1A CACNA1B CACNA1E HCAR2 APOC2 LBR CHRNA4 CCKAR CHRNB3 CCKBR CHRND CHRNE CACNG2 HCAR3 P2RY2 | 1.60e-06 | 688 | 113 | 15 | CID000002551 |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 4.25e-08 | 3 | 104 | 3 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 1.70e-07 | 4 | 104 | 3 | DOID:6364 (implicated_via_orthology) | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 2.57e-07 | 16 | 104 | 4 | DOID:3635 (implicated_via_orthology) | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.47e-06 | 7 | 104 | 3 | DOID:0050951 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 1.87e-06 | 163 | 104 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | Myasthenic Syndrome, Congenital, Fast-Channel | 3.68e-05 | 3 | 104 | 2 | C1837122 | |
| Disease | functional colonic disease (biomarker_via_orthology) | 3.68e-05 | 3 | 104 | 2 | DOID:3877 (biomarker_via_orthology) | |
| Disease | blood pressure, response to thiazide, response to beta blocker | 3.68e-05 | 3 | 104 | 2 | EFO_0004325, EFO_0007766, EFO_0007981 | |
| Disease | polyp of gallbladder | 7.35e-05 | 4 | 104 | 2 | MONDO_0021416 | |
| Disease | MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL | 7.35e-05 | 4 | 104 | 2 | C4084823 | |
| Disease | Kohlschutter-Tonz syndrome (implicated_via_orthology) | 1.22e-04 | 5 | 104 | 2 | DOID:0111668 (implicated_via_orthology) | |
| Disease | Acute myelomonocytic leukemia | 1.22e-04 | 5 | 104 | 2 | C0023479 | |
| Disease | Bartter syndrome | 1.83e-04 | 6 | 104 | 2 | cv:C0004775 | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 2.55e-04 | 7 | 104 | 2 | DOID:0060178 (implicated_via_orthology) | |
| Disease | cholesteryl ester 24:4 measurement | 2.55e-04 | 7 | 104 | 2 | EFO_0021447 | |
| Disease | pancreatic cancer (biomarker_via_orthology) | 2.55e-04 | 7 | 104 | 2 | DOID:1793 (biomarker_via_orthology) | |
| Disease | duodenal ulcer | 2.79e-04 | 36 | 104 | 3 | EFO_0004607 | |
| Disease | Bipolar Disorder | 2.92e-04 | 477 | 104 | 8 | C0005586 | |
| Disease | alcohol-related neurodevelopmental disorder (implicated_via_orthology) | 3.40e-04 | 8 | 104 | 2 | DOID:0050667 (implicated_via_orthology) | |
| Disease | familial hyperlipidemia (is_implicated_in) | 3.40e-04 | 8 | 104 | 2 | DOID:1168 (is_implicated_in) | |
| Disease | irritable bowel syndrome (biomarker_via_orthology) | 3.40e-04 | 8 | 104 | 2 | DOID:9778 (biomarker_via_orthology) | |
| Disease | time to first cigarette measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0010126 | |
| Disease | total lipids in small LDL | 6.16e-04 | 47 | 104 | 3 | EFO_0022168 | |
| Disease | free cholesterol in medium VLDL measurement | 6.16e-04 | 47 | 104 | 3 | EFO_0022269 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 6.49e-04 | 195 | 104 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | total lipids in lipoprotein particles measurement | 6.56e-04 | 48 | 104 | 3 | EFO_0022309 | |
| Disease | TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) | 7.94e-04 | 12 | 104 | 2 | C1861063 | |
| Disease | phospholipids in medium VLDL measurement | 8.29e-04 | 52 | 104 | 3 | EFO_0022154 | |
| Disease | depressive disorder (biomarker_via_orthology) | 8.29e-04 | 52 | 104 | 3 | DOID:1596 (biomarker_via_orthology) | |
| Disease | cholesterol in small VLDL measurement | 8.77e-04 | 53 | 104 | 3 | EFO_0022228 | |
| Disease | total lipids in medium VLDL | 9.26e-04 | 54 | 104 | 3 | EFO_0022153 | |
| Disease | colitis (implicated_via_orthology) | 9.36e-04 | 13 | 104 | 2 | DOID:0060180 (implicated_via_orthology) | |
| Disease | Cocaine Abuse | 1.08e-03 | 127 | 104 | 4 | C0009171 | |
| Disease | phospholipids in VLDL measurement | 1.20e-03 | 59 | 104 | 3 | EFO_0022301 | |
| Disease | Malignant neoplasm of skin | 1.20e-03 | 59 | 104 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 1.20e-03 | 59 | 104 | 3 | C0037286 | |
| Disease | phospholipids in small VLDL measurement | 1.26e-03 | 60 | 104 | 3 | EFO_0022146 | |
| Disease | free cholesterol in VLDL measurement | 1.32e-03 | 61 | 104 | 3 | EFO_0022276 | |
| Disease | Cocaine Dependence | 1.51e-03 | 139 | 104 | 4 | C0600427 | |
| Disease | Acute myeloid leukemia | 1.62e-03 | 17 | 104 | 2 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 1.62e-03 | 17 | 104 | 2 | 601626 | |
| Disease | Anorexia | 1.81e-03 | 18 | 104 | 2 | C0003123 | |
| Disease | Cholecystitis | 2.02e-03 | 19 | 104 | 2 | HP_0001082 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.14e-03 | 153 | 104 | 4 | EFO_0004611, EFO_0020946 | |
| Disease | sorbitol measurement | 2.97e-03 | 23 | 104 | 2 | EFO_0010533 | |
| Disease | Anhedonia | 3.23e-03 | 24 | 104 | 2 | C0178417 | |
| Disease | tobacco smoke exposure measurement | 3.23e-03 | 24 | 104 | 2 | EFO_0009115 | |
| Disease | Dystonia | 3.52e-03 | 86 | 104 | 3 | C0013421 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KAMIPLLQIGLLLFF | 221 | O00555 | |
| LVIPLIGEYLLFTMI | 301 | P43681 | |
| KVIPLIGEYLLFIMI | 291 | Q05901 | |
| IPLIGKFLLFGMVLV | 306 | Q07001 | |
| MGPVRLGILLFLFLA | 1 | Q8N129 | |
| MGTRLLPALFLVLLV | 1 | P02655 | |
| KAMVPLLQIGLLLFF | 216 | Q15878 | |
| LLFMIGALIPFNVIL | 451 | Q9H221 | |
| INILGLVIPLGIMLF | 206 | P51679 | |
| LLIILLMPVLLIGYF | 91 | Q5VYY1 | |
| TFLLLILFLIPGIVM | 211 | P32238 | |
| MSAVLLLALLGFILP | 1 | Q8N6Q3 | |
| LLLLLLFFIPGVVMA | 221 | P32239 | |
| FIPLIIIGSFFMLNL | 336 | Q00975 | |
| AMVIQGPLFLLFTLL | 1736 | Q8IZY2 | |
| VPLLGRFLIFVMVVA | 301 | Q04844 | |
| LFILIVFIFLMALIG | 26 | Q8NG85 | |
| FLLLLLIALEIMVGG | 16 | Q8TD07 | |
| MAVVIRLLGLPFIAG | 1 | Q8IXT5 | |
| MARILLLFLPGLVAV | 1 | Q9NRC9 | |
| FIFIMSLLLISGQRP | 11 | P0DMC3 | |
| FLIMFGLPVFLFLLL | 216 | Q14739 | |
| PLFLAFLVIYLITIM | 26 | A6NDH6 | |
| PLFLAFLVIYLITIM | 26 | P0DN80 | |
| FLMALGLFVPAILLV | 261 | O95907 | |
| IFPILSVILLFMGGL | 106 | Q9Y698 | |
| GPAAIALMILAFLLL | 611 | Q14126 | |
| PLFLAFLVIYLITIM | 26 | A6NHG9 | |
| LFGFLILLPEIVMIS | 166 | Q8NGY3 | |
| MLLLFLIVVLLGLFA | 856 | A6BM72 | |
| VLFLFLGILTMLRPN | 146 | Q96A54 | |
| LLAILGGMAFILLVL | 306 | Q5VUB5 | |
| MPLFFSALLVLLLVA | 1 | Q14667 | |
| IVPFMEFLLPVFLKL | 186 | Q2VYF4 | |
| FPLSGLLMVLLSTIF | 196 | A8MXT2 | |
| SPKLGLLMVLLSIIF | 366 | Q9UNF1 | |
| AVFIMLLIGIVLPVF | 221 | Q5XG99 | |
| LFTPLLIGFVIVAGM | 521 | P10721 | |
| AMFLLEFFLPLGIIL | 191 | Q8TDS4 | |
| LFILFVLIFLMALIG | 26 | Q8NG80 | |
| ATLVLLPLLGITYML | 311 | Q13324 | |
| FLLIGLPTIPVMLIL | 141 | Q9NX47 | |
| PLNFPLRIFLLIVFM | 626 | O60337 | |
| LMALLPIFFGALRSV | 41 | Q8TCT9 | |
| FMILITSIFTLLLPF | 196 | Q8NG92 | |
| IGIVFSFKSMLLVLP | 146 | Q8NGJ7 | |
| IGIVFSFKSMLLVLP | 146 | Q8NGJ6 | |
| VYIFLIFMVLILPSL | 506 | O94886 | |
| MSVSFLIFLPVLGLP | 1 | A0A0B4J1U7 | |
| VMLGLLFAVPFAVIL | 201 | P41231 | |
| LVIMVPFLLILISYG | 206 | Q8NGX3 | |
| FILLGFPLSLRIQML | 11 | Q96R48 | |
| PLFLAFLVIYLITIM | 26 | A6NKK0 | |
| PIVLILLGLLLFKMY | 491 | Q8NA29 | |
| IMPLTAFVLGKVFRL | 71 | Q14973 | |
| LPLLVVFSAMIFGTI | 11 | P36888 | |
| MTLFPVLLFLVAGLL | 1 | P54108 | |
| VILLILVFMVPFYIG | 81 | B7ZAQ6 | |
| VILLILVFMVPFYIG | 81 | P0CG08 | |
| LLFFLLFLTPMEVRP | 6 | P15391 | |
| TLKVILGFFLPFVVM | 216 | P51686 | |
| FLIFMVLLLPSLGLS | 521 | Q5T3F8 | |
| LMITAILLGFLGLLL | 81 | P56746 | |
| LVLLPLLGITYMLFF | 346 | P34998 | |
| MKIFLPVLLAALLGV | 1 | Q16553 | |
| MGFTTPLLLVLLYLQ | 326 | Q5T1A1 | |
| METFPLLLLSLGLVL | 1 | Q8TAA1 | |
| PAPLILGFMLVTAFL | 121 | Q13183 | |
| VTALLPIVLFPFMGI | 61 | Q8WWT9 | |
| PLLSGIMSGILFFLV | 166 | Q8WUM9 | |
| IQMFFTLGIIILPGI | 246 | O75751 | |
| FMGGLILVIPFLLLI | 201 | Q8WZA6 | |
| GVLLMIPFPFLVKRL | 161 | Q8NH56 | |
| FLMAVFILIGSLIPT | 196 | Q8NGT5 | |
| ILGILMTIGFILLLV | 91 | P13164 | |
| IMGGLILVIPFLLIL | 201 | P30953 | |
| VRLFVILVPMGLVFI | 201 | Q8NGY7 | |
| ILVPMGLVFISYVLI | 206 | Q8NGY7 | |
| MLGVFALVIPLLLIL | 201 | Q8NGX5 | |
| IITMGLLFLTVPLLL | 216 | Q8NGR9 | |
| VLLFLGGAVILIPFM | 211 | Q8NH06 | |
| MVVPLVFLLLRLPFC | 161 | Q6IFG1 | |
| FLPVGFVTLSLSLMI | 261 | Q92521 | |
| KSVILVMLLGPLLFL | 126 | P59538 | |
| GIFVPLIMFILAATL | 201 | P59535 | |
| KSVILVMLLGPLLFL | 126 | P59537 | |
| MIPFLILLVLEGIPL | 71 | Q695T7 | |
| LPYLILLMVIGIPLF | 101 | Q9H2J7 | |
| LLMVIGIPLFFLELS | 106 | Q9H2J7 | |
| TFPFAMLLVLLVRGL | 251 | P31641 | |
| IFMLFLVGVPLLFLE | 146 | Q9GZN6 | |
| MFALGLPFLVLLVAS | 1 | Q8NBJ9 | |
| IGLPLGILLTFVVRM | 451 | Q86VL8 | |
| FLLFLLLVGAMFLLP | 361 | Q8N205 | |
| AMFLLEFFLPLGIIL | 191 | P49019 | |
| VFLTFMGTVLLLLLL | 36 | K7EJ46 | |
| FFFTPLMTLVTLLIL | 31 | A0A5F9ZH02 | |
| FFFMLLGSLLPVKII | 16 | Q9BRY0 | |
| GKLFIAPLIMVLGLA | 496 | Q8TC41 | |
| LMAVFVLFGSLIPTI | 201 | Q8NGU2 | |
| FLIIFPPLVMGLKLD | 151 | A6NF89 | |
| LAGPAFLVQLMVFLI | 41 | Q96FL8 | |
| LHATLPGIFMLLLIF | 341 | O75908 | |
| LTGLLVILYGMLLLV | 171 | Q09428 | |
| FLMFIILGIPLPLGT | 796 | Q13733 | |
| FMPIFILGAAIGRLL | 426 | P51800 | |
| MGIFPGIILIFLRVK | 1 | O95258 | |
| MGRFLLLVILFLPRE | 11 | Q6UXZ0 | |
| ILLLGLVIVFGPTMF | 321 | O60858 | |
| LVPFTLLPLLTMAYL | 346 | Q8TCT6 | |
| LMDSLLPVLGVLFLL | 471 | Q9C0B7 | |
| LVLLVYGLAFMVILP | 191 | Q9UGP8 | |
| LLLGLMAFLILPRVT | 916 | Q4G0T1 | |
| FVILLPLSLILMVFG | 106 | B3SHH9 | |
| LLIPFILLIFMLRSP | 151 | Q5BJF2 | |
| GLFGFVILSLLLVPM | 216 | Q8N357 | |
| FGLVLALIGLIFLMV | 311 | P0DKB5 | |
| FIIFGVFLPLSMLIT | 1176 | Q01118 | |
| MGLLLLVLFLSLLPV | 696 | Q8TDI7 | |
| GVLMIFPALVFLGLK | 56 | P48230 | |
| LMIIAPSLGFVLFAL | 316 | Q96H15 | |
| MLVRSVGLFLVGLLL | 111 | Q66K66 |